Delivery system for aided replacement valve recapture and repositioning post-deployment

Description

BACKGROUND
Field

Certain embodiments disclosed herein relate generally to prostheses for implantation within a lumen or body cavity and delivery systems for implanting a prosthesis. In particular, the prostheses and delivery systems relate in some embodiments to replacement heart valves, such as replacement mitral heart valves.

Description of the Related Art

Human heart valves, which include the aortic, pulmonary, mitral and tricuspid valves, function essentially as one-way valves operating in synchronization with the pumping heart. The valves allow blood to flow downstream, but block blood from flowing upstream. Diseased heart valves exhibit impairments such as narrowing of the valve or regurgitation, which inhibit the valves' ability to control blood flow. Such impairments reduce the heart's blood-pumping efficiency and can be a debilitating and life threatening condition. For example, valve insufficiency can lead to conditions such as heart hypertrophy and dilation of the ventricle. Thus, extensive efforts have been made to develop methods and apparatuses to repair or replace impaired heart valves.

Prostheses exist to correct problems associated with impaired heart valves. For example, mechanical and tissue-based heart valve prostheses can be used to replace impaired native heart valves. More recently, substantial effort has been dedicated to developing replacement heart valves, particularly tissue-based replacement heart valves that can be delivered with less trauma to the patient than through open heart surgery. Replacement valves are being designed to be delivered through minimally invasive procedures and even percutaneous procedures. Such replacement valves often include a tissue-based valve body that is connected to an expandable frame that is then delivered to the native valve's annulus.

Development of prostheses including but not limited to replacement heart valves that can be compacted for delivery and then controllably expanded for controlled placement has proven to be particularly challenging. An additional challenge relates to the ability of such prostheses to be secured relative to intralumenal tissue, e.g., tissue within any body lumen or cavity, in an atraumatic manner.

Delivering a prosthesis to a desired location in the human body, for example delivering a replacement heart valve to the mitral valve, can also be challenging. Obtaining access to perform procedures in the heart or in other anatomical locations may require delivery of devices percutaneously through tortuous vasculature or through open or semi-open surgical procedures. The ability to control the deployment of the prosthesis at the desired location can also be challenging.

SUMMARY

Embodiments of the present disclosure are directed to a prosthesis, such as but not limited to a replacement heart valve. Further embodiments are directed to delivery systems, devices and/or methods of use to deliver and/or controllably deploy a prosthesis, such as but not limited to a replacement heart valve, to a desired location within the body. In some embodiments, a replacement heart valve and methods for delivering a replacement heart valve to a native heart valve, such as a mitral valve, are provided.

In some embodiments, a delivery system and method are provided for delivering a replacement heart valve to a native mitral valve location. The delivery system and method may utilize a transseptal or transapical approach. In some embodiments, components of the delivery system facilitate bending of the delivery system to steer a prosthesis from the septum to a location within the native mitral valve. In some embodiments, a capsule is provided for containing the prosthesis for delivery to the native mitral valve location. In other embodiments, the delivery system and method may be adapted for delivery of implants to locations other than the native mitral valve.

The present disclosure includes, but is not limited to, the following embodiments.

Embodiment 1

A delivery system for a replacement valve. The delivery system can comprise a tether configured to releasably hold a replacement valve, a torqueing manifold configured to retain a first end of the tether, and an engagement pin configured to move from a locked position to an unlocked position, the engagement pin configured to releasably retain a second end of the tether, wherein longitudinal translation of the engagement pin from the locked position to the unlocked position releases the second end of the tether and the replacement valve from the delivery system, and wherein rotational movement of the torqueing manifold with respect to the engagement pin is configured to crimp or uncrimp a portion of the replacement valve.

Embodiment 2

The delivery system of Embodiment 1, further comprising a manifold shaft having the torqueing manifold on a distal end of the manifold shaft, the torqueing manifold having at least one protrusion extending distally from a distal end of the torqueing manifold, a bearing rotatably retained within the torqueing manifold, and a pin lock shaft having a release plate located proximal of the bearing and located on a distal end of the pin lock shaft, wherein the pin lock shaft is configured to engage the engagement pin in the locked position and the unlocked position.

Embodiment 3

The delivery system of Embodiment 2, wherein circumferential rotation of the manifold shaft with respect to the pin lock shaft is configured to crimp or uncrimp the portion of the replacement valve.

Embodiment 4

The delivery system of any one of Embodiments 2-3, wherein the engagement pin extends between the release plate and the bearing in the locked position, and wherein the second end of the tether is retained on the engagement pin between the release plate and the bearing in the locked position.

Embodiment 5

The delivery system of any one of Embodiments 2-4, wherein the manifold shaft is located within a lumen of the pin lock shaft, wherein the pin lock shaft is configured to longitudinally and rotationally translate with respect to the manifold shaft, and wherein proximal translation of the pin lock shaft releases the engagement pin from the bearing which releases the second end of the tether from the engagement pin

Embodiment 6

The delivery system of any one of Embodiments 2-5, wherein the torqueing manifold comprises a plurality of distally extending protrusions extending around an outer circumference of the distal end of the torqueing manifold.

Embodiment 7

The delivery system of any one of Embodiments 1-6, wherein the engagement pin is generally L-shaped.

Embodiment 8

The delivery system of any one of Embodiments 1-7, further comprising the replacement valve, wherein the replacement valve is a replacement mitral valve.

Embodiment 9

The delivery system of any one of Embodiments 1-8, wherein the tether is configured to pass through an eyelet of the replacement valve.

Embodiment 10

A method of releasing a replacement valve from a delivery system, the method comprising expanding the replacement valve from a compressed configuration to an expanded configuration, the replacement valve having a distal end and a proximal end, the replacement valve releasably attached to the delivery system at a location distal to the replacement valve through at least one tether, and rotating a manifold shaft located radially inwards of the replacement valve in a first direction with respect to a locking shaft, wherein the manifold shaft has a manifold on a distal end located distal to the replacement valve, wherein the at least one tether is connected to the manifold and the locking shaft, and wherein the manifold shaft is located within a lumen of the locking shaft, wherein the rotating the manifold shaft in the first direction loosens the at least one tether to uncrimp the distal end of the replacement valve.

Embodiment 11

The method of Embodiment 10, wherein the expanding the replacement valve comprises proximally translating an outer sheath to uncover the proximal end of the replacement valve, and distally translating a nosecone to uncover the distal end of the replacement valve.

Embodiment 12

The method of Embodiment 10 or Embodiment 11, further comprising rotating the manifold shaft in a second direction opposite the first direction with respect to the locking shaft to crimp the distal end of the replacement valve.

Embodiment 13

The method of Embodiment 12, further comprising proximally translating a nosecone to cover the distal end of the replacement valve when the replacement valve is crimped.

Embodiment 14

The method of any one of Embodiments 10-13, further comprising proximally translating the locking shaft with respect to the manifold shaft to release at least one end of the at least one tether from the delivery system, wherein the release of the at least one end releases the replacement valve from the delivery system.

Embodiment 15

The method of any one of Embodiments 10-14, wherein the replacement valve is releasably attached to the delivery system via a plurality of tethers.

Embodiment 16

A crimping ring for a replacement valve, the crimping ring comprising a generally circular body having an inner lumen extending longitudinally therethrough and a plurality of longitudinally extending apertures on an outer circumference of the body, and a plurality of sutures, each of the sutures extending through one of the plurality of apertures and configured to extend proximally from a replacement valve, wherein applying a proximally directed force on one of the plurality of sutures is configured to cause an angular change in the position of the body and the replacement valve, and wherein applying a proximally directed force on all of the plurality of sutures generally at the same time provides proximal longitudinal translation of the body which is configured to at least partially compress a distal end of the replacement valve.

Embodiment 17

The crimping ring of Embodiment 16, wherein the replacement valve crimp and tilt ring comprises three sutures and wherein the body has three apertures spaced generally evenly around the outer circumference.

Embodiment 18

The crimping ring of any one of Embodiments 16-17, wherein each of the plurality of sutures is wrapped around the body and passes through one of the plurality of apertures.

Embodiment 19

The crimping ring of any one of Embodiments 16-18 further comprising the replacement valve attached to a delivery system via a second plurality of sutures extending through the inner lumen of the body, wherein the replacement valve is a replacement mitral valve.

Embodiment 20

The crimping ring of Embodiment 19, wherein the proximal longitudinal translation of the replacement valve crimp and tilt ring radially compresses the second plurality of sutures and the distal end of the replacement mitral valve prosthesis as the second plurality of sutures and the replacement mitral valve prosthesis pass through the inner lumen.

Embodiment 21

A delivery system for releasing a replacement valve. The delivery system can comprise a torqueing manifold. The torqueing manifold can have a protrusion. The protrusion can extend distally from a distal end. The torqueing manifold can be located on a distal end of a manifold shaft. The delivery system can further comprise a bearing. The bearing can be rotatably retained within the torqueing manifold. The delivery system can further comprise a release plate. The release plate can be located proximal of the bearing. The release plate can be located on a distal end of a pin lock shaft. The delivery system can further comprise an engagement pin. The engagement pin can extend between the release plate and the bearing. The delivery system can further comprise a suture. A first end the suture can be connected to the protrusion. A second end of the suture can be connected to the engagement pin between the release plate and the bearing. The suture can be configured to pass through an engagement aperture in a replacement valve. The manifold shaft can be located within a lumen of the pin lock shaft. The pin lock shaft can be configured to longitudinally translate with respect to the manifold shaft. Proximal translation of the pin lock shaft can release the engagement pin from the bearing and can release the second end of the suture from the engagement pin. Circumferential rotation of the manifold shaft with respect to the pin lock shaft can be configured to crimp or uncrimp the replacement valve.

Embodiment 22

A delivery system for a replacement valve. The delivery system can comprise a suture. The suture can be configured to pass through an eyelet of a replacement valve. The delivery system can comprise an inner member. The inner member can be configured to retain the first end of the suture. The delivery system can comprise an engagement pin. The engagement pin can be configured to move from a locked position to an unlocked position. The engagement pin can be configured to retain a second end of the suture. Longitudinal translation of the engagement pin from the locked position to the unlocked position can release the second end of the suture and the replacement valve from the delivery system. Rotational movement of the inner member with respect to the engagement pin is configured to crimp or uncrimp a portion of the replacement valve.

Embodiment 23

A method of releasing and recapturing a replacement valve from a delivery system. The method can comprise proximally translating an outer sheath to uncover a proximal end of a replacement valve. The method can comprise distally translating a nosecone to uncover a distal end of the replacement valve. The method can comprise rotating a manifold shaft in a first direction to uncrimp the distal end of the replacement valve. The method can comprise rotating the manifold shaft in a second direction to crimp the distal end of the replacement valve. The method can comprise proximally translating the nosecone to cover the distal end of the replacement valve.

Embodiment 24

A replacement valve crimp and tilt ring. The ring can comprise a body having an inner lumen extending longitudinally. The body can have a plurality of apertures on an outer circumference of the body extending longitudinally. The inner lumen can be configured to receive an end of a replacement valve. The ring can comprise a plurality of sutures. Each of the sutures can be connected to one of the plurality of apertures and can extend proximally. Applying a proximally directed force on one of the plurality of sutures causes an angular change in the position of the circular body and the replacement valve. Applying a proximally directed force on all of the plurality of sutures at the same time provides proximal longitudinal translation of the body to at least partially compress the end of the replacement valve.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates an embodiment of a delivery system for a valve.

FIGS. 2-6 show a side views of embodiments of a valve prostheses that may be delivered using the delivery systems described herein.

FIG. 7 illustrates a distal end of an embodiment of a delivery system.

FIG. 8 illustrates an embodiment of a valve prosthesis release structure.

FIG. 9 illustrates an embodiment of a release pin.

FIG. 10 illustrates an embodiment of a distal end of a delivery system with a valve prosthesis release structure.

FIGS. 11A-11C illustrate an embodiment of a manifold.

FIG. 12 illustrates an embodiment of a bearing.

FIG. 13 illustrates an embodiment of a release plate and tether guide.

FIG. 14 illustrates a cross section of a distal end of an embodiment of a delivery system.

FIGS. 15A-15B illustrate a distal end of an embodiment of a delivery system with the manifold removed.

FIGS. 16A-16B illustrate an embodiment of a valve tilt and crimp ring.

FIG. 17 illustrates an embodiment of a valve tilt and crimp ring with attached sutures.

FIG. 18 illustrates an embodiment of the valve tilt and crimp ring during crimping.

FIG. 19 illustrates a cross section of an embodiment of the delivery device.

FIGS. 20-24 illustrate an embodiment of an implantation procedure of a replacement valve using the delivery device.

FIG. 25 illustrates a transapical approach for a delivery device.

FIGS. 26-28B illustrate steps of a transapical method for delivery of a valve prosthesis to replace a mitral valve.

DETAILED DESCRIPTION

The present specification and drawings provide aspects and features of the disclosure in the context of several embodiments of replacement heart valves, delivery systems, and methods that are configured for use in the vasculature of a patient, such as for replacement of natural heart valves in a patient. These embodiments may be discussed in connection with replacing specific valves such as the patient's aortic or mitral valve. However, it is to be understood that the features and concepts discussed herein can be applied to products other than heart valve implants. For example, the controlled positioning, deployment, and securing features described herein can be applied to medical implants, for example other types of expandable prostheses, for use elsewhere in the body, such as within an artery, a vein, or other body cavities or locations. In addition, particular features of a valve, delivery system, etc. should not be taken as limiting, and features of any one embodiment discussed herein can be combined with features of other embodiments as desired and when appropriate. While certain of the embodiments described herein are described in connection with a transapical delivery approach, it should be understood that these embodiments can be used for other delivery approaches such as, for example, transseptal approaches. Moreover, it should be understood that certain of the features described in connection with some embodiments can be incorporated with other embodiments, including those which are described in connection with different delivery approaches.

Transapical Delivery System

FIG. 1 illustrates an embodiment of a delivery device or system 100. The delivery system 100 can be used to deploy a prosthesis/implant, such as a replacement heart valve as described elsewhere in this specification, within the body. The delivery system 100 can receive and/or cover portions of the prosthesis such as a first end and second end of the implant.

The delivery system 100 can be used to deploy a prosthesis, such as a replacement heart valves as described elsewhere in this specification, within the body. The delivery system 10 can receive and/or cover portions of the prosthesis such as a first end 301 and second end 303 of the prosthesis (or implant) 70 illustrated in FIG. 2 below. For example, the delivery system 100 may be used to deliver an expandable implant or prosthesis 70, where the prosthesis 70 includes the first end 301 (or atrial end) and the second end 303 (or ventricular end), and wherein the second 303 end is configured to be deployed or expanded before the first end 301. In some embodiments, the tabs 74 of the prosthesis 70 shown in FIG. 2 may include eyelets (or apertures) 214 for attaching tethers as discussed below.

FIG. 3 illustrates an alternate embodiment of a valve prosthesis 1010 which can be used in conjunction with the delivery systems disclosed herein. The illustrated prosthesis 1010 includes a frame 1020 that may be self-expanding or balloon expandable. The prosthesis 1010 may be a replacement valve that can be designed to replace a damaged or diseased native heart valve such as a mitral valve, as discussed above. The additional features of the replacement valve are not shown in FIG. 3 in order to more clearly illustrate features of the frame 1020. It will also be understood that the prosthesis 1010 is not limited to being a replacement valve. In addition, it will be understood in FIG. 3, that only a front portion of the frame 1020 is shown for further ease of illustration. In some embodiments, the tabs 1023 may include eyelets 214 for attaching tethers as discussed below.

FIGS. 4-6 illustrate alternative embodiment of a prosthesis 70 that can used with the disclosed delivery system 100 and methodology discussed herein. These embodiments can have similar or the same features to the prostheses discussed herein. In some embodiments, the prosthesis may be a single frame prosthesis. In some embodiments, the prosthesis may be a dual frame prosthesis. For example, as shown in FIG. 6, a prosthesis 70 can include an inner frame 71a and an outer frame 71b. In some embodiments, the outer frame 71b can be conformable for placement in the native mitral valve annulus and the inner frame 71a can support the valve assembly 90. As shown, the prostheses 70 of FIGS. 4-6 can contain eyelets (or apertures) 214 for receiving the tethers discussed below. Further details on these specific embodiments can be found in U.S. Patent Publication Nos. 2018/0021129 and 2018/0055629, which have been incorporated by reference in their entirety.

Additional details and example designs for a prosthesis are described in U.S. Pat. Nos. 8,403,983, 8,414,644, 8,652,203 and U.S. Patent Publication Nos. 2011/0313515, 2012/0215303, 2014/0277390, 2014/0277422, 2014/0277427, and 2016/0317301 the entirety of these patents and publications are hereby incorporated by reference and made a part of this specification. Further details and embodiments of a replacement heart valve or prosthesis and its method of implantation are described in U.S. Patent Publication No. 2015/0328000, the entirety of which is hereby incorporated by reference and made a part of this specification.

Replacement heart valves can be delivered to a patient's heart mitral valve annulus or other heart valve location in various ways, such as by open surgery, minimally-invasive surgery, and percutaneous or transcatheter delivery through the patient's vasculature. The delivery system 100 illustrated in FIG. 1 can be relatively short to more easily be used in an open heart procedure or other more direct procedures than the percutaneous procedure starting at the leg. At the same time, the delivery system 100 can still be relatively flexible to allow, for example, advancement through the pulmonary veins or the wall of the left atrium and then bending of the delivery device for proper placement at the mitral valve. In some embodiments, the delivery system 100 is particularly suitable for delivering a replacement heart valve to a mitral valve location through a transapical approach (e.g., through the apex of the heart).

With reference first to the embodiment illustrated in FIG. 1, the delivery system 100 can include a handle 110 and a plurality of sheaths and/or shafts such as the illustrated outer elongate hollow member shaft 114. As will be described in further detail below, the plurality of shafts can be sized and shaped to be slidable relative to each other. Accordingly, it should be understood that one or more of the plurality of shafts can be concentric with respect to another of the shafts to facilitate slidable movement of the shafts relative to each other. The plurality of shafts can be coupled to one or more other components of the delivery system 100. In some embodiments, the handle 110 can include a plurality of switches, levers, knobs, or other actuatable/rotatable mechanisms which can be used to control the movement of the one or more shafts of the delivery system 100 and/or to control the operation of other components of the delivery system 100.

With continued reference to the embodiment of FIG. 1, the delivery system 100 can include outer elongate hollow member shaft 114 having a proximal and distal end. As used to describe the components of the delivery system, “proximal” refers to a location of the component that is closer to the handle 110, and “distal” refers to a location of the component that is further from the handle 110. In some embodiments, the proximal end of the outer elongate hollow member shaft 114 can be coupled to the handle 110. In some embodiments, the outer elongate hollow member shaft 114 can be fixed relative to the handle 110. In some embodiments, the outer elongate hollow member shaft 114 can be movable relative to the handle 110. The outer elongate hollow member shaft 114 can include sheath and/or capsule, and may be made of one or multiple members. The outer elongate hollow member shaft 114 can have the same diameter from the proximal to distal end, or the diameter may vary. The outer elongate hollow member shaft 114 can be formed from a variety of materials, including ePTFE and PEEK, as well as other biocompatible materials. Further, the outer elongate hollow member shaft 114 can include a coating, such as a hydrophilic coating.

In some embodiments, the outer elongate hollow member shaft 114 can cover at least a portion of a collapsed or compressed prosthesis 70 while the prosthesis 70 is being delivered to the deployment site. For example, the outer elongate hollow member shaft 114 can cover at least the second end 303 of the prosthesis 70 while the first end 301 of the prosthesis 70 is received within a hollow nose cone 118, described further below. In some embodiments, the outer elongate hollow member shaft 114 can also cover the first end 301 of the prosthesis 70. The outer elongate hollow member shaft 114 can be sized and shaped such that the outer elongate hollow member shaft 114 can retain the prosthesis 70 in a compressed state as it is delivered to the deployment site. Accordingly, the outer elongate hollow member shaft 114 can function as a “capsule” for receiving the prosthesis 70. As shown in the illustrated embodiment, the outer elongate hollow member shaft 114 can have a constant or substantially constant outer diameter throughout the entirety, or a substantial portion of the entirety, of its length. The outer elongate hollow member shaft 114 can be moveable relative to the nose cone 118 to uncover the second end 303 of the prosthesis 70 while the first end 301 of the prosthesis 70 remains engaged to tether retention mechanism (described below) within the nose cone 118 and remains covered by the nose cone 118.

The outer elongate hollow member shaft 114 can include a marker 117 positioned proximate the distal end, such as a radiopaque marker that allows for visualization by a physician. In some embodiments, the outer elongate hollow member shaft 114 can be formed of multiple layers of material, such that the outer elongate hollow member shaft 114 includes at least a first radial portion and a second radial portion. This can advantageously allow for the use of two types of material for the outer elongate hollow member shaft 114. For example, at least a portion of the first portion can be positioned radially outward from the second portion relative to a central longitudinal axis of the outer elongate hollow member shaft 114. The first portion, which may be considered an outer layer, can be formed from a relatively rigid material, such as PEBAX, ULTEM, PEEK and any other biocompatible material as desired. This can advantageously provide some degree of rigidity for the outer portion of the elongate hollow member shaft 114. The second portion, which may be considered an inner layer, can be formed from a more compliant material, such as PTFE, ePTFE and any other biocompatible material as desired. This can advantageously provide a more compliant inner surface for the outer elongate hollow member shaft 114, which can be beneficial when contacting other components of the delivery system 100 and the prosthesis. In some embodiments, the second portion can be a liner which is applied to the first portion.

While the outer elongate hollow member shaft 114 can be formed with multiple portions formed from multiple materials, it is also contemplated that the outer elongate hollow member shaft 114 can be a formed from a single material.

Additionally, the innermost shaft in the delivery system 100 can be the nose cone shaft which has a proximal end operably connected to the handle 110 and a distal end coupled to nose cone 118. The nose cone shaft may be hollow along its length to receive a guidewire, though in some embodiments the nose cone shaft is not hollow. Nose cone 118 can include an elongate, hollow portion with a proximally facing opening, and a tapered distal portion (as shown in FIG. 1). The nose cone shaft may be coupled to the nose cone 118 such that the nose cone shaft extends through the proximal opening, though the connection is not limiting. The nose cone 118 can further contain a lumen extending from the distal end of the nose cone shaft to the distal end of the nose cone 118, which can allow a guide wire to pass through. The nose cone 118 can be formed from a relatively rigid, high durometer material. The nose cone 118, including both the elongate, hollow portion and the tapered, distal portion, can have a length, measured from the distalmost end to a proximalmost end, of between approximately 5 mm to 50 mm, between approximately 10 mm to approximately 40 mm, between approximately 15 mm to approximately 25 mm, approximately 20 mm, any other lengths within these ranges, and any other lengths as desired.

The outermost diameter of the nose cone 118 can be similar to, or equal to, the outer diameter of an outer shaft and/or outer component, such as the outer elongate hollow member shaft 114. This can form a generally smooth transition in diameter between the nose cone 118 and the outer shaft and/or the outer component if and when the nose cone 118 is brought into contact with the outer shaft and/or the outer component. In some embodiments, the nose cone 118 can have an outer diameter of approximately 31 Fr or 32 Fr and the outer shaft and/or outer component can have an outer diameter of approximately 31 Fr or 32 Fr.

In some embodiments, the outer diameter of the nose cone 118 can be similar to, or equal to, the inner diameter of the outer elongate hollow member shaft 114 such that nose cone 118 can be partially received within the outer elongate hollow member shaft 114. In some embodiments, the nose cone 118 can have an outer diameter of approximately 30 Fr and the outer shaft and/or outer component can have an inner diameter of approximately 30 Fr. In some embodiments, the outer shaft can be an outermost shaft of the delivery system.

The tether retention configuration discussed below can cooperate with the nose cone 118 to release a first end 301 of the prosthesis from the nose cone 118. The first end 301 of the prosthesis 70 can be placed in a compressed state such that the first end 301 of the prosthesis 70 is retained within the nose cone 118 when the nose cone 118 is in the proximal position. Distal movement of the nose cone 118 can release the first end 301 of the prosthesis 70 from the nose cone 118, allowing it to expand. If the prosthesis 70 is not covered by the outer elongate hollow member shaft 114, once the nose cone 118 is moved distally to uncover the first end 301 of the prosthesis 70, the first end 301 of the prosthesis 70 may completely self-expand from its compressed state to an expanded configuration.

Additional details and example designs for transapical delivery systems are described in U.S. Patent Publication No. 2017/0056169, the entirety of which is hereby incorporated by reference and made a part of this specification. Further details and embodiments of a transapical delivery systems and methods of delivery are described in U.S. Patent Pub. Nos. 2018/0116790 and 2017/0056169, the entirety of each of which is hereby incorporated by reference and made a part of this specification.

Tether Prosthesis Retention

FIG. 7 illustrates an embodiment of a distal end 202 of a delivery system 100 using one or more tethers (e.g., sutures, cords, ropes, tapes) to releasably retain the prosthesis 70 on the delivery system 100 after full expansion/partial expansion/release (e.g., tether retention mechanism), while also providing additional functionality of crimping or uncrimping the prosthesis 70, such as for recapture. For convenience of viewing, the nosecone 118, nosecone shaft, and the outer elongate hollow member shaft 114 (discussed above with respect to FIG. 1) have been removed. Similar design and release methodology as discussed in U.S. Patent Publication No. 2017/0056169 can be used, with the inner retention member being replaced by the structure discussed herein. The other components discussed in 2017/0056169 may be incorporated into the delivery system 100, such as the nosecone 118 and the outer elongate hollow member shaft 114 which can constrain the prosthesis 70 in a compressed configuration.

Advantageously, embodiments of the delivery system 100 allow the prosthesis 70 to be fully expanded (e.g., released from the nosecone 118 and the outer elongate hollow member shaft 114) but remain attached to the delivery system 100 through the use of one or more tethers. This allows the prosthesis 70 to be maneuvered after expansion, such as by translating the delivery system 100 or different shafts within the delivery system 100, for optimizing the position of the prosthesis 70 in a patient. The delivery system 100 further allows the prosthesis 70 to be compressed and withdrawn back into one or more sheathing members (e.g., nosecone 118/outer elongate hollow member shaft 114) if positioning and placement is undesirable. Thus, the prosthesis 70 may be recaptured by the delivery system 100 after expansion.

In order to use the tether attachment system, the delivery system 100 discussed above can be modified. For example, the nosecone 118 and outer elongate hollow member shaft 114 shown in FIG. 1 can be used to radially compressibly retain the first end 301 and second end 303 of the prosthesis 70, respectively, when the outer elongate hollow member shaft 114 is in its distalmost position and the nosecone 118 is in its proximalmost position. Thus, the nosecone 118 can be advanced distally and the outer elongate hollow member shaft 114 can be retracted proximally, either simultaneously or separately, to release the prosthesis 70, thereby expanding the prosthesis 70 from a compressed configuration to an expanded configuration, giving the configuration schematically shown in FIG. 8 (with the outer elongate hollow member shaft 114 and nosecone 118 removed for convenience). This operation can be performed by a user at the handle 110 of the delivery system, such as through the use of the knobs shown in FIG. 1.

FIG. 8 illustrates a simplified version of distal end 202 of the delivery system 100 for convenience of explanation with the prosthesis 70 in the released (or expanded) position. Starting from the distal-most end, the delivery system 100 can include a manifold (or torqueing manifold, crown, tether attachment mechanism) 204, a bearing 206, one or more release pins 208 (e.g., members, shafts, bars), a release plate 210, and one or more tethers 212, each of which will be discussed below in more detail. In some embodiments, the manifold 204 can fit partially or fully within the nosecone 118 prior to deployment and/or after recapture, and the outer elongate hollow member shaft 114 can be slidable over the remaining components. In the closed configuration, the distal end of the outer elongate hollow member shaft 114 can abut the proximal end of the nosecone 118 to radially constrain the prosthesis 70 in a compressed configuration. The nosecone 118 can translate distally/proximally with respect to the manifold 204. The outer elongate hollow member shaft 114 can translate distally/proximally with respect to the manifold 204. Distal advancement of the nosecone 118 can uncover and release the first end 301 of the prosthesis 70, and proximal advancement of the outer elongate hollow member shaft 114 can uncover and release a second end 303 of the prosthesis 70. In particular, this approach can be used for a transapical delivery approach.

As shown in the schematic of FIG. 8, a first end of the tethers 212 (e.g., fixed end) can be attached to the manifold 204, such as at a distal end of the manifold 204, though the attachment location is not limiting. The tethers 212 can wrap around protrusions 236 at the distal end of the manifold 204 (shown in FIG. 11A) or can be otherwise physically constrained, such as with clamps, locks, friction, etc., on the manifold 204. In some embodiments, the tethers 212 can be chemically adhered to the manifold 204. The tethers 212 can extend proximally from the manifold 204 and pass through the eyelets (e.g., apertures) 214 of the prosthesis 70, such as shown in the first end 301 of the prosthesis of FIGS. 4-6. In some embodiments, the prostheses of FIGS. 2-3 can also include apertures 214 on tabs 74 as indicated. However, alternately the tethers 212 can otherwise wrap around or releasably interact/connect with the prosthesis 70, such as with those shown in FIGS. 2-3, and the disclosure is not so limited by the apertures or attachment mechanism to the prosthesis 70.

After attaching to the prosthesis 70, the tethers 212 can extend distally (e.g., towards the manifold 204) from the prosthesis 70 where the second end of the tethers 212 (e.g., temporary or removable end) can be attached onto, for example, release pins 208. The tethers 212 can attach to the release pins 208 such as by looping around a portion of the release pins 208, though the particular attachment is not limiting. Thus, the prosthesis 70, in particular the first end 301, can be held onto the delivery system 100 through the use of the tethers 212 after expansion of the prosthesis 70. Additionally, as shown, the manifold 204 and/or the release pins 208 and/or bearing 206 can be located generally distally to the prosthesis 70 in the expanded state. In some embodiments, a second manifold can be located proximal to the prosthesis 70, and a similar configuration can be used to attach the second end 303 to the secondary manifold. Alternatively, a tether loop attached to the handle 110 can at least partially surround the second end 303 to slow expansion, such as discussed in U.S. Pat. Publication No. 2017/0056169.

Further, FIG. 8 shows a schematic of prosthesis 70 in the uncrimped and expanded state where the prosthesis 70 is relatively freely floating, though still attached to the delivery system 100 by the tethers 212. As shown, the tethers 212 can be attached to a portion of the first end 301 of the prosthesis 70. As discussed in more detail, the expanded prosthesis 70 can be crimped down (e.g., compressed) so that the first end 301 wraps around and outer circumferential surface 205 of the manifold 204 or other portion of the delivery system 100, either for the initial expansion of the first end 301 or for recapture of the first end 301. Specifically, spooling (or tensioning) and unspooling (or untensioning) of the tethers 212 between the delivery system and the prosthesis 70 can crimp/uncrimp the prosthesis 70.

The delivery system 100 can include the same, more, or less tethers 212 than apertures 214 on the prosthesis 70. In some embodiments, the delivery system 100 can use 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 tethers 212 for connecting the prosthesis 70 to the delivery system 100. In some embodiments, each aperture 214 contains a different tether 212. In some embodiments, a tether 212 may pass through multiple apertures 214. While FIG. 8 only shows two tethers for convenience, it will be understood that every aperture 214 of the valves of FIGS. 2-6 can receive a different tether, or that apertures may not be required. In some embodiments, a single unbroken tether 212 may be used. The tethers 212 can be configured to stretch in certain embodiments, or relatively unstretchable in other embodiments.

As mentioned above, the second end of the tethers 212 can releasably attach onto release pins 208, such as by a tether loop which can slide along the release pins 208, as shown in FIG. 8. In some embodiments, each tether 212 can attach to a different release pin 208. In some embodiments, a release pin 208 may be attached to by multiple tethers 212. In some embodiments, a tether 212 may attach to more than one release pin 208.

In some embodiments, the release pins 208 have a generally L-shape with a straight portion 214 attached to a bent portion 216 to form the L as shown in FIG. 9. In certain implementations, the bent portion 216 can be located at the proximal end of the release pins 208. In some embodiments, straight portion 214 can consist of 90, 95, 98, or 99% of the length of the release pin 208. In some embodiments, the bent portion 216 can be at an angle of about 80, 85, 90, 95, 100, 105, 110, 115, 120, or 125° with respect to the straight portion 214. In some embodiments, the release pins 208 may have enlarged pin heads instead of the bent portion 216, or other mechanism to prevent distal motion through the release plate 210. In some embodiments, the release pins 208 can include threading, where the release pins 208 rotate upon proximal translation.

As shown in FIG. 10, when in the locked position, the straight portion 214 of the release pins 208 can extend distally towards an inner proximal surface of the manifold 204. In some embodiments, the manifold 204 can include indentations or other capture mechanisms to receive the distal ends of the straight portions 214. As shown, the straight portion 214 can extend through apertures in bearing 206 which can be located within the manifold 204 in order to make sure the pins 208 remain aligned. Near the proximal end of the pins 208, the straight portion 214 of the pins 208 pass through apertures in the release plate 210 and the bent portion 216 remains on the proximal end of the release plate 210, on a pin retention face, preventing any further distal motion of the pins 208 due to the bent portion 216 not fitting through apertures in the release plate 210. Further, excess proximal motion of the pins 208, which could release the tethers 212, is prevented as the pins 208 would abut a distal end of the suture guide 218. Thus, as shown in FIGS. 8 and 10 in the locked position the second end of the tethers 212 are held on the pins 208 between the bearing 206 and the release plate 210, preventing release of the releasable end of the tethers 212 (and thereby preventing release of the prosthesis 70).

When it is desirable to release the prosthesis 70 from the delivery system 100, the release plate 210 can be translated (e.g., pulled, moved) proximally, such as by a user at a handle 110 of the delivery system 100, thus providing a proximal force on the bent portion 216 and pulling the pins 208 proximally with respect to the bearing 206. A user can pull on a portion of a handle 110, or activate an actuator (such as a button or knob) to withdraw the release plate 210. Once the pins 208 are fully pulled proximally through the bearing 206, the straight portions 212 come free from the bearing 206 and the tethers 212 are released as the bearing 206 no longer blocks the path of the second end of the tethers 212 (the first end of the tether 212 continues to remain on the manifold 204). In some embodiments, as the tethers 212 are under tension when attached they will automatically be released from the pins 208 once the pins 208 are released from the bearing 206. In some embodiments, the tethers 212 can be manually removed from the pins 208 by a user. Once the second end of the tethers 212 are released from the pins 208, the prosthesis 70 can fully release from the delivery system 100.

FIG. 10 illustrates a more detailed embodiment of a distal end of the delivery system shown in FIG. 8, and includes some further components which may be used in some embodiments. For example, FIG. 10 illustrates two shafts, the pin lock shaft 220 and the manifold shaft 222, the manifold shaft 222 being concentrically located within a lumen of the pin lock shaft 220. The distal end of the manifold shaft 222 can connect to the manifold 204, such as shown in FIG. 10. The distal end of the pin lock shaft 220 can connect to the release plate 210 and/or the tether guide 218, discussed below. The pin lock shaft 220 can be translated distally and proximally, such as by a user at a handle 110 of the delivery system 100, to release the pins 208 as discussed above. The manifold shaft 222 can further include a lumen for other components, such as a nosecone shaft discussed above, to pass through. Further, either the pin lock shaft 220 or the manifold shaft 222, or both shafts, can be configured for rotational motion with respect to each other, such as by a user at a handle 110 of the delivery system 100, as discussed below. Additionally, the outer elongate hollow member shaft 114 can translate over the pin lock shaft 220 in order to compress the prosthesis 70. Thus, the pin lock shaft 220 and the manifold shaft 222 can be located within a lumen of the outer elongate hollow member shaft 114.

As shown in FIG. 10, some embodiments of the delivery system 100 can include a tether guide 218 located proximal of the release plate 210. The tether guide 218 can include a number of apertures for the tethers 212 to pass through, thus preventing tangling of the tethers 212, and assisting in the crimping/uncrimping of the prosthesis 70. As shown, the tethers can extend from the manifold 204 to enter a distal end of the tether guide 218 and pass out the proximal end of the tether guide 218 through the prosthesis 70 and back distally to the release pin 208. However, this particular approach is not limiting and the tethers may enter/exit either side of the tether guide 218. In some embodiments, the tether guide 218 is attached to the release plate 210. In some embodiments, the tether guide 218 may not be used. In some embodiments, the tether guide 218 may only be a protrusion that prevents proximal motion of the pins 208.

Moving to the individual components, FIGS. 11A-11C illustrate the manifold 204 removed from the delivery system 100. The manifold 206 can include a distal end 232 and a proximal end 234. The manifold 206 can be sized to fit within a nosecone, or to abut against a proximal end of a nosecone. As shown, the distal end 232 can include a crown of tabs (e.g., protrusions, jaws) 236 surrounding a ring-shaped gap 238, which in turn surrounds a raised circular protrusion 240. The protrusion 240 can include an aperture 242 generally in the middle and extending proximally to distally, which can receive one or more shafts, such as a nosecone shaft.

The tabs 236 can be used to wrap/wind one end of the tether 212 around (such as by using a loop), thereby retaining the tether 212 onto the manifold 204. In some embodiments, the tabs 236 can be bent or crushed inwards in order to permanently retain the end of the tether 212. In some embodiments, the tethers 212 can be permanently affixed to the manifold 204 through other means, such as by adhesives or mechanical fastening. As shown, the manifold 204 can include twelve tabs 236 for twelve tethers 212, though the particular number of tabs does not limit the disclosure. There can be the same number of tabs 236 as there are tethers 212. For example, there can be 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 tabs 236. Moving radially inwards is a gap 238 which has a general ring shape, and inwards of the gap 238 is the raised circular protrusion 240. The gap 238 can be sized configured to allow the protrusions 236 to bend into the gap 238 to hold the tethers 212.

Moving proximally, the diameter of the manifold 204 can be reduced, for example in a step reduction, though in other embodiments there is no reduction of diameter. Therefore, the proximal end 234 of the manifold 204 can have a smaller diameter than the distal end 232, such as ¼, ⅓, or ½ the diameter. This makes it so the first end 301 of the prosthesis 70 can circumferentially surround the proximal end 234 proximal the step, such as at surface 205, in the fully crimped position and be within the diameter of the distal end 232 so that the prosthesis 70 does not get caught by the nosecone 118 upon recapture. As shown in FIG. 11B, the proximal end 234 can include a larger diameter aperture 244, extending proximally to distally, than the aperture 242 on the distal end 232. The aperture 244 can form a hollow space 243, for example generally cylindrical, within the manifold 204. Accordingly, the manifold shaft 222 can fit within the aperture 244 and into the hollow space but not extend through aperture 242. Further, the hollow space can receive the bearing 206, as shown in FIG. 10.

FIG. 11C illustrates a cross section of the manifold 204 with the bearing 206. In some embodiments, the hollow space 243 can include indentations 246 to receive and retain the bearing 206, such as shown in FIG. 10. In some embodiments, the bearing 206 can be snap fit into the manifold 204.

Next, FIG. 12 shows the bearing 206. As shown, the bearing 206 can be generally shaped like a ring or cylinder, though the particular shape is not limiting. The bearing 206 can include a center aperture (or lumen) 252 extending proximally to distally which can be sized to receive the manifold shaft 222, which can retain a nosecone shaft in its inner lumen. The bearing 206 can further include a number of smaller apertures 254 around its circumference, extending from the proximal side to the distal side. The apertures 254 can be sized to receive the straight portion 214 of the release pins 208. The apertures 254 can be evenly spaced around the circumference in some embodiments. There can be an equal number of apertures 254 as there are release pins 208, for example 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 apertures 254. However, there may be more apertures 254 than release pins 208 in some implementations.

Further, in certain implementation the bearing 206 can include notches 256 on an outer circumferential surface of the bearing 206. The notches can be aligned with the apertures 254 in some implementations. In some embodiments, an inner surface of the manifold 204 can include protrusions that mate with the notches 256 for proper initial alignment, though the bearing 206 is free to circumferentially rotate within the manifold 204 after initial insertion. Other implementations include protrusions on the bearing 206 and notches on the inner surface of the manifold 204. In some embodiments, notches are not used on the bearing 206. In some embodiments, the bearing 206 is free to rotate circumferentially within the manifold 204 and around the manifold shaft 222. This allows proper alignment of the release pins 208 with respect to the release plate 210.

Moving proximally on the delivery system 100, FIG. 13 illustrates the combination of the release plate 210 and the tether guide 218. As shown, a center shaft 262 can connect the centers of the release plate 210 and tether guide 218 so that the components are longitudinally spaced apart. The release plate 210, tether guide 218, and center shaft 262 can all include a single lumen 264 for a shaft, such as the manifold shaft 222, to pass through. The center shaft 262 may have a smaller diameter than the tether guide 218 and the release plate 210. In some embodiments, a center shaft 262 is not used, and the tether guide 218 and release plate 210 can be two separate components. For example, the release plate 210 can be located at the distal end of the pin lock shaft 220 and the tether guide 218 can be spaced proximally from the release plate 210 on the pin lock shaft 220. Both the release plate 210 and the tether guide 218 can be generally cylindrical or ringlike in shape.

The release plate 210 can be similar to the bearing 206 discussed above, and can have a number of apertures 266 extending proximally to distally and spaced around the outer circumference for receiving the release pins 208. The apertures 266 can be sized to receive the straight portion 214 of the release pins 208, but prevent the bent portion 216 from translating distally. The apertures 266 can be evenly spaced around the circumference in some embodiments, and can generally align with the apertures 254 on the bearing 206. There can be an equal number of apertures 266 as there are release pins 208, for example 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 apertures 266. In some embodiments, there are more apertures 266 than release pins 208.

The tether guide 218 can also include a number of apertures 268 on an outer circumference extending proximally to distally configured to allow the tethers 212 to pass through. In some embodiments, there can be as many apertures 268 as tethers 212 or as protrusions 236 on the manifold 204. For example, there can be 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 apertures 268. The tether guide 218 may have the same diameter as the release plate 210, or may have a greater diameter than the release plate 210.

FIG. 14 illustrates a cross section of the distal end of the delivery system showing one pin 208. FIGS. 15A-15B illustrate the distal delivery system with the manifold removed 204 for clarity, showing the connection of the pins 208 between the release plate 210 and the bearing 206.

As discussed above, embodiments of the delivery system 100 can be used to retain the prosthesis 70 after expansion. Thus, the prosthesis 70 can be moved within a patient by moving the delivery system 100 upon release of the prosthesis 70.

Advantageously, components in the delivery system 100 can be torqued or rotated to provide crimping/uncrimping forces onto the prosthesis 70, in particular the first end 301 which is attached by tethers 212. Specifically, the manifold shaft 222 can be circumferentially rotated within the lumen of the pin lock shaft 220. Alternatively, the pin lock shaft 220 can be circumferentially rotated with respect to the manifold shaft 222. This can be done by the user, for example at the handle 110 such as through knobs or other actuators. Thus, the manifold 204 (holding the first end of the tethers 212) can be rotated with respect to the engagement pins 208 (holding the second end of the tethers 212). Accordingly, the tethers 212 will be pulled tight as the ends of the tethers 212 move away from one another, and the tethers 212 will loosen as the ends are moved towards one another. This tightening and loosening of the tethers 212 will pull the first end 301 of the prosthesis 70 radially inwards, thus causing crimping/uncrimping of the prosthesis 70. When the prosthesis 70 is crimped, the nosecone can be slid over the first end 301 of the prosthesis 70 for recapturing of the prosthesis 70.

Embodiments of the disclosed delivery system 100 can be inserted into a patient, such as in a transapical approach. The prosthesis 70 can be generally aligned with the native mitral valve (or other valve). The nosecone 118 can be advanced distally, thereby uncovering the first end 301 of the prosthesis 70, which allows the prosthesis 70 to begin expansion. The prosthesis 70 is still attached to the delivery system 100 by the tethers 212. Further, the outer elongate hollow member shaft 114 can be translated proximally to release the second end 303 of the prosthesis 70, which allows the prosthesis 70 to be fully expanded while still connected to the delivery system 100 by the tethers 212.

Upon full expansion of the prosthesis 70, it can be determined whether the prosthesis 70 is located in the proper position within the patient. If necessary, the manifold shaft 222 and pin lock shaft 220 can be circumferentially rotated with respect to one another to crimp at least the first end 301 of the prosthesis 70. The nosecone 118 can then be proximally retracted to cover the first end 301, so that the prosthesis 70 can be repositioned or withdrawn from the patient.

Once the prosthesis 70 is in the correct position, it can be released from the delivery system 100. For example, the pin lock shaft 220 can be translated proximally, thereby releasing the pins 208 from the bearing 206. Once released, the tethers 212 are released from the pins 208, thereby disconnecting the prosthesis 70 from the delivery system 100. The delivery system 100 can then be withdrawn through a lumen in the prosthesis 70 for removal. In some embodiments, the nosecone is retracted proximally and the outer elongate hollow member shaft can be advanced distally so that the two components contact one another. This can alleviate any issues of the delivery system 100 catching on the prosthesis 70 during removal. In other implementations, the nosecone and outer elongate hollow member shaft do not need to be moved after release of the prosthesis 70 for removal of the delivery system 100.

While the above description discusses the use of tethers and pins for releasable connection of the prosthesis, other engagement mechanisms can be used as well and the disclosure is not so limited. For example, the tethers can be releasably attached by clips, locks or clamps to a portion of the delivery system 110. Additionally, frictional components or chemicals/adhesives can be used which can be overcome by an applied force greater than that applied by the expanded prosthesis 70. Further, other locking structures can be manipulated to release one or more ends of the tether, such as at the handle 110 of the delivery system 100. Thus, while the above tethers can be used to connect the prosthesis 70 to the handle 110, other methods or release can be used, and the disclosure is not so limited.

In some embodiments, a similar structure as described above, but reversed proximally/distally, can be used to retain the second end 303 of the prosthesis 70. For example, the manifold 204 can be located proximal to the prosthesis 70 and the position of the prosthesis 70 and manifold 204 can be reversed (e.g., the first end 301 is proximal to the second end 303). Accordingly, the tether guide 218 and release plate 210 will be aligned distal to the prosthesis 70. Thus, a transseptal delivery system, such as disclosed in U.S. Patent Pub. No. 2017/0056171, hereby incorporated in its entirety, can be used with the components discussed above. For example, the outer retention ring/midshaft and the inner retention ring/inner shaft can be replaced with the manifold/locking shafts discussed above.

Valve Crimp and Tilt Ring

Disclosed are embodiments of a valve crimp and tilt ring (e.g., crimping ring) for aided prosthesis recapture and repositioning post-deployment. In some embodiments, it can be advantageous to be able to reposition the prosthesis 70 after partial or full expansion of the valve from the delivery system. Further, it may be necessary to partially or fully recapture a partially or fully expanded prosthesis 70 for a number of reasons, such as incorrect positioning within a heart. Embodiments of the disclosed ring can be optionally used with respect to the suturing retention mechanism discussed above. However, in some embodiments the ring is not used. Further, the ring system can be used without the suturing retention system discussed above.

In some embodiments, the ring may be used to crimp the prosthesis 70 instead of the rotational torqueing discussed above the manifold shaft 222. In some embodiments, the ring may fit within a nosecone 118 of the delivery system 100. For example, the ring may freely float within the nosecone 118. In some embodiments, the ring can allow the nosecone 118 to have a 30 French outer diameter, a 27 French outer diameter, or less than 30 French or less than 27 French outer diameter.

FIGS. 16A-16B illustrate different views of the ring 400. The ring 400 includes a body 402, in some embodiments a generally circular or ring-body, with a large center lumen 404 extending proximally to distally and a number of apertures 406 extending proximally to distally through the body 402. While the ring 400 of FIGS. 16A-16B has a thickness (e.g., proximally to distally) less than the diameter, in some embodiments the thickness can be equal to or greater than the diameter, thereby forming a tube or cylinder instead of a ring.

The lumen 404 can be sized to receive and surround a portion of the prosthesis 70, in particular the first end 301 of the prosthesis 70, along with the tethers 212 attaching the prosthesis 70 to the manifold 204 discussed above. Prior to any crimping, the ring 400 can be located distal to the prosthesis 70.

As mentioned, the ring 400 can include a number of the smaller apertures 406. In some embodiments, they are spaced evenly around the circumference of the ring 400. In some embodiments, they are not spaced evenly around the circumference of the ring 400. The ring 400 can include 1, 2, 4, 5, 6, 7, 8, 9, or 10 apertures 404. In some embodiments, the apertures 406 may be notched.

The apertures 404 can be configured to receive and hold the ends of sutures (e.g., tethers, threads, cords, tapes) which can extend proximally through the delivery system 100, for example through lumens of various shafts. An example of the sutures 408 (in this case three sutures) attaching and extending away is shown in FIG. 17. The sutures 408 may pass through the apertures 404 and form a loop around the ring 400, or can be attached by other mechanical/adhesive methods. The second end of the sutures 408 can extend to a user, either by exiting the delivery system 100 or attaching to knobs/switches/actuators in a handle 110 of the delivery system 100. The prosthesis 70 may be located partially or fully radially within the sutures 408, proximal to the ring 400. There may be no further reattachment of the ring 400 to the delivery system 100.

When one of the sutures 408 is pulled in a proximal direction, the ring 400 can then tilt in the direction of the pull. As the sutures 212 attached to the prosthesis 70 are held within the ring 400 such as shown in FIG. 18, this force also causes tilting of the prosthesis 70. Thus, the prosthesis 70 can be moved in three-dimensional space upon expansion from the delivery system 100. Stating in another way, unequal loading of tension of the individual sutures 408 allows for tilting of the prosthesis 70 that would be useful in repositioning of the prosthesis 70 during an implantation.

Further, when the ring 400 is pulled proximally by all of the sutures 408 at the same time, the sutures 212 attached to the prostheses 70 can be compressed inwards into the lumen 404 and the first end 301 of the prosthesis 70 can be compressed to fit within the lumen 404 as shown in FIG. 18. Thus, the ring 400 can “ride along” the sutures 212, compressing them radially inwards. Further proximal pulling and motion of the ring 400 can slide along at least a portion of the prosthesis 70, and in some embodiments may slide completely proximal of the prosthesis 70. As the diameter of the lumen 404 is smaller, equal to, or slightly larger, than the diameter of the first end 301, the first end 301 can be compressed to fit within the lumen 404. This can allow the nosecone 118 to slide back over the first end 301, thereby recapturing the prosthesis 70 in the delivery system 100.

Release of Valve

The embodiments of FIGS. 19-24 illustrates steps of a method of operating the delivery system 100 and releasing an intralumenal frame assembly, such as prosthesis 70, to intralumenal tissue at an in situ target location. The steps of this method can be carried out while the prosthesis 70 is in a radially compacted state within the outer elongate hollow member shaft 114. In some embodiments, the longitudinal axis of the prosthesis 70, which runs between the first 301 and second ends 303 of the prosthesis 70, can be parallel to and/or concentric with the longitudinal axis of one or more shafts of the delivery system 100. The steps of this method can be used to transapically deliver a replacement heart valve to a mitral valve location.

FIG. 19 shows a cross section of the delivery system 100 with the prosthesis 70 located in the delivery position. For ease of illustration, the prosthesis 70 is shown in FIG. 19 with only its metal frame illustrated, and the suturing system discussed above has been removed. As shown, the outer elongate hollow member shaft 114 covers the prosthesis 70, thus preventing expansion of the prosthesis 70, in particular the second end 303. Further, the ventricular anchors 80 of the prosthesis 70 extend proximally toward the handle 110, with the outer elongate hollow member shaft 114 radially restraining the ventricular anchors 80 pointing proximally. The outer elongate hollow member shaft 114 extends distally to the nose cone 118, which covers the inner retention member 134. The first end 12 of the prosthesis 70 is positioned with struts 72 held with the suturing system discuss above and covered by the nose cone 118. Further, in some embodiments a tether 136 extends distally from the handle 110, within the outer elongate hollow member shaft 114, through one of the guide members 226, and is wrapped around the prosthesis 70, more preferably wrapping around the ventricular anchors 80 that extend proximally. The tether 136 then extends proximally to the tether retention member 134 located within the locking shaft 122, where the end of the tether 136 is locked in position as described above.

With reference next to the step of FIG. 20, once the delivery system 100 has positioned the prosthesis 70 at the in situ target location, the outer elongate hollow member shaft 114 can be moved relatively away from the nose cone 118, either by proximally retracting the outer elongate hollow member shaft 114 and/or distally advancing the nose cone 118 to uncover at least a portion of the prosthesis 70, in particular the second end 303 of the prosthesis 70. As shown in FIG. 20, there may be a slight bulge in the prosthesis 70 during this phase.

With reference next to the step of FIG. 21, the outer elongate hollow member shaft 114 can be further moved relatively away from the nose cone 118 to further uncover the prosthesis 70. As shown in the illustrated embodiment, the second end 303 of the prosthesis 70 has been uncovered with the tether 136 being the only component restraining the radial dimension of the frame of the prosthesis 70. By maintaining tension on the tether 136, the tether 136 can continue to at least partially restrain the radial dimension of the second end and can advantageously reduce the speed at which the second end radially expands. The tether 136 can be continuously released by the user at the handle 110 until the second end of the prosthesis 70 is fully expanded. In some embodiments, the tether 136 can be configured such that the first end 301 remains in the fully compacted state when the second end 303 is fully uncovered.

It should be noted that the first end 301 of the prosthesis 70 can remain covered by the nose cone 118 during this step such that the first end 301 remains in a radially compacted state. Moreover, as shown in the illustrated embodiment, the second end 303 of the prosthesis 70 has at least partially expanded in the radial dimension with the ventricular anchors 80 having been flipped to extend distally away from the second end of the prosthesis 70 (and distally away from the handle 110). By controlling the expansion of the second end 303 of the prosthesis 70 with the tether 136, the user can minimize the risk of the ventricular anchors 80 catching on surrounding tissue when the ventricular anchors 80 flip from extending proximally to extending distally.

As shown in FIG. 22, once the second end 303 of the prosthesis 70 is fully expanded, the locking shaft 122 can be moved relatively proximally to expose the tether retention member 134, thus allowing the tether 136 to fully release from the tether retention member 134.

Next, as shown in FIG. 23, the tether retention member 134 has released the end 138 of the tether 136. It should be noted that the first end 301 of the prosthesis 70 can remain covered by the nose cone 118 during this step such that the first end 301 remains in a radially compacted state. As discussed below, the tether 136 and end 138 can be retracted proximally into the delivery system 100 at this point. In some embodiments, the tether 136 and the locking shaft 122 are not used.

With reference next to the step of FIG. 24, the suture retention mechanism, such as manifold 204, discussed in detail above can be moved relatively away from the nose cone 118 such that the first end of the prosthesis 70 can radially expand to its fully expanded configuration. This can be achieved by either distally moving the nose cone 118 relative to the manifold 204 and/or moving the manifold 204 proximally relative to the nose cone 118. As discussed, the prosthesis 70 can remain attached to the delivery system 100 in the fully expanded state until the sutures are release as discussed above.

After expansion and release of the prosthesis 70, the different distal end attachment components and the nose cone 118 can be withdrawn through the center of the prosthesis 70 and into the outer elongate hollow member shaft 114.

The delivery device 100 may be provided to users with an prosthesis 70 preinstalled, such as illustrated in FIG. 19. In other embodiments, the prosthesis 70 can be loaded onto the delivery device 100 shortly before use, such as by a physician or nurse.

Further discussion on the release of the valve are described in U.S. Pat. Pub. No. 2017/0056169, hereby incorporated by reference in its entirety.

Insertion Methodology

FIG. 25 illustrates a transapical approach for use with the delivery device 100. As shown, the delivery device 100 can access a mitral valve through the apex 7 of the heart. As depicted in FIG. 25, a guide wire 2001 is advanced into the left ventricle 6 of the heart through a puncture or opening 9 near the apex 7. The heart may be accessed through a limited thoracotomy, small trocar puncture, or small catheter puncture. With the guide wire 2001 in place, the physician can insert the device 100 to the left ventricle 6 and deploy the heart valve as disclosed above. In some embodiments, a guide wire is not used. A balloon can be inserted into the left atrium 1078 and expanded to confirm that the guide wire 2001 has not been advanced through any of the chordae 110 or papillary muscles.

In some embodiments, the prosthesis 70 can be delivered under fluoroscopy so that a user can view certain reference points for proper positioning of the prosthesis 70. Further, echocardiography can be used for proper positioning of the prosthesis 70.

FIGS. 26-28B show different steps of embodiments of a method of delivering the prosthesis 70 to the proper position in the heart.

Prior to insertion of the delivery system 100, the access site into the patient can be dilated. Further, a dilator can be flushed with, for example, heparinized saline prior to use. The delivery system 100 can then be inserted over a guide wire 2001.

The delivery system 100 can be advanced until a distal end of the delivery system 100 through the left ventricle 1070 and mitral annulus 106 into the left atrium 1078. Thus, the distal end of the delivery system 100 can be located in the left atrium 1078. In some embodiments, the delivery system 100 can be rotated, such as under fluoroscopy, into a desired position. The position of the delivery system 100, and the prosthesis 70 inside, can be verified using echocardiography and fluoroscopic guidance.

In some embodiments, the prosthesis 70 can be located, prior to release, above the mitral annulus 106, in line with the mitral annulus 106, just below the mitral annulus 106, or below the mitral annulus 106. In some embodiments, the prosthesis 70 can be located, prior to expansion, fully above the mitral annulus 106, in line with the mitral annulus 106, just below the mitral annulus 106, or fully below the mitral annulus 106. In some embodiments, the prosthesis 70 can be located, prior to expansion, partially above the mitral annulus 106, in line with the mitral annulus 106, or partially below the mitral annulus 106.

In some embodiments, the position of the mitral plane and the height of any papillary muscles 2004 on the fluoroscopy monitor can be marked to indicate an example target landing zone.

Further, the delivery system 100 can be positioned to be coaxial to the mitral annulus 106, or at least as much as possible, while still reducing contact with the left ventricular wall, the left atrial wall, and/or the mitral annulus 106 and reducing delivery system tension. An echo probe can be position to view the anterior mitral leaflet (AML), the posterior mitral leaflet (PML) (leaflets 108), mitral annulus 106, and outflow tract. Using fluoroscopy and echo imaging, the prosthesis 70 can be confirmed to be positioned at a particular depth and coaxiality with the mitral annulus 106.

Afterwards the prosthesis 70 is aligned to be generally perpendicular to the mitral annulus 106, the elongate hollow member shaft 114 can be retracted to expose the left ventricular anchors 80. In some embodiments, once exposed, the elongate hollow member shaft 114 can be reversed in direction to relieve tension on the elongate hollow member shaft 114. The tether 136 can keep the prosthesis 70 from quickly expanding.

An embodiment of the position of the delivery system 100 for release of the ventricular anchors 80 is shown in FIG. 27A. As shown, the ventricular anchors 80 can be released in the left atrium 1078, such as by proximal movement of the outer elongate hollow member shaft 114. In some embodiments, only the ventricular anchors 80 are released from the delivery system 100. In some embodiments, the ventricular end of the prosthesis 70 does not expand with released of the ventricular anchors 80. However, in some embodiments, one or more of the ventricular anchors 80 can be released in either the left atrium 1078 (e.g., super-annular release), generally aligned with the mitral valve annulus 106 (e.g., intra-annular release), or just below the mitral valve annulus 106 (e.g., sub-annular release). In some embodiments, all of the ventricular anchors 80 can be released together. In other embodiments, a subset of the ventricular anchors 80 can be released while at a first position and another subset of the ventricular anchors 80 can be released while at a second position.

As discussed in detail above, upon release from the delivery system 100, the ventricular anchors 80 can flip from extending distally to extending proximally. Accordingly, in some embodiments, the ventricular anchors 80 can be flipped in either the left atrium 1078 (e.g., super-annular flip), generally aligned with the mitral valve annulus 106 (e.g., intra-annular flip), or below the mitral valve annulus 106 (e.g., sub-annular flip). The ventricular anchors 80 can be released and flipped in the left atrium 1078 (or generally aligned with the mitral valve annulus 106) or in the left ventricle 1080. The atrial anchors 82 can remain within the delivery system 100. In some embodiments, all of the ventricular anchors 80 can be flipped together. In other embodiments, a subset of the ventricular anchors 80 can be flipped while at a first position and another subset of the ventricular anchors 80 can be released while at a second position. For example, some of the ventricular anchors 80 can be flipped in the left atrium 1078 and some of the ventricular anchors 80 can be flipped while generally aligned with the mitral valve annulus 106 or just below the mitral valve annulus 106.

In some embodiments, the ventricular anchors 80 may be positioned in line with the annulus 106 in the non-flipped position. In some embodiments, the ventricular anchors 80 may be position in line with the annulus 106 in the flipped position. In some embodiments, the ventricular anchors 80 may be just below the annulus 106 in the non-flipped position. In some embodiments, the ventricular anchors 80 may be just below the annulus 106 in the flipped position. In some embodiments, prior to flipping the ventricular side of the prosthesis 70 can be located within or below the mitral valve annulus 106. However, flipping the anchors can cause, without any other movement of the delivery system 100, the ventricular side of the prosthesis 70/anchors 80 to move upwards, moving it into the left atrium 1078 or moving it in line with the mitral annulus 106. Thus, in some embodiments the ventricular anchors 80 can begin flipping at the annulus 106 but be fully within the left atrium 1078 upon flipping. In some embodiments the ventricular anchors 80 can begin flipping below the annulus 106 but be generally in line with the annulus 106 upon flipping.

In some embodiments, the ventricular anchors 80 can be distal (e.g., toward the left atrium 1078) of a free edge of the mitral leaflets 108 upon release and flipping. In some embodiments, the ventricular anchors 80 can be aligned with (e.g., toward the left atrium 1078) a free edge of the mitral leaflets 108 upon release and flipping. In some embodiments, the ventricular anchors 80 can be distal (e.g., toward the left atrium 1078) of a free edge of the mitral valve annulus 106 upon release and flipping. In some embodiments, the ventricular anchors 80 can be aligned with (e.g., toward the left atrium 1078) a free edge of the mitral valve annulus 106 upon release and flipping. In some embodiments, the ventricular anchors 80 can be proximal (e.g., toward the left ventricle 1080) of a free edge of the mitral leaflets 108 upon release and flipping.

Thus, in some embodiments the ventricular anchors 80 can be released/flipped above where the chordae 110 attach to the free edge of the native leaflets 108. In some embodiments the ventricular anchors 80 can be released/flipped above where some the chordae 110 attach to the free edge of the native leaflets 108. In some embodiments the ventricular anchors 80 can be released/flipped above where all the chordae 110 attach to the free edge of the native leaflets 108. In some embodiments, the ventricular anchors 80 can be released/flipped above the mitral valve annulus 106. In some embodiments, the ventricular anchors 80 can be released/flipped above the mitral valve leaflets 108. In some embodiments, the ventricular anchors 80 can be released/flipped generally in line with the mitral valve annulus 106. In some embodiments, the ventricular anchors 80 can be released/flipped generally in line with the mitral valve leaflets 108. In some embodiments, the tips of the ventricular anchors 80 can be released/flipped generally in line with the mitral valve annulus 106. In some embodiments, the tips of the ventricular anchors 80 can be released/flipped generally in line with the mitral valve leaflets 108. In some embodiments the ventricular anchors 80 can be released/flipped below where some the chordae 110 attach to the free edge of the native leaflets 108. In some embodiments the ventricular anchors 80 can be released/flipped below where all the chordae 110 attach to the free edge of the native leaflets 108. In some embodiments, the ventricular anchors 80 can be released/flipped below the mitral valve annulus 106. In some embodiments, the ventricular anchors 80 can be released/flipped below the mitral valve leaflets 108.

Once the ventricular anchors 80 are released and flipped, the delivery system 100 can be translated back towards the left ventricle 1080 through the mitral valve annulus 106 so that the ventricular anchors 80 enter the left ventricle 1080 as shown in FIG. 27B. In some embodiments, the ventricular anchors 80 compress when passing through the mitral valve annulus 106. In some embodiments, the prosthesis 70 can compress when passing through the mitral valve annulus 106. In some embodiments, the prosthesis 70 does not compress when it passes through the mitral annulus 106. The system 100 can be released anywhere within the left ventricle 1080 between the papillary heads and the leaflets 108.

In some embodiments, the ventricular anchors 80 are fully expanded prior to passing through the mitral valve annulus 106, such as the tether 136 being fully released. In some embodiments, the ventricular anchors 80 are partially expanded prior to passing through the mitral valve annulus 106, such as the tether 136 maintaining tension, and continued operation of the delivery system 100 can fully expand the ventricular anchors 80 in the left ventricle 1080.

When the ventricular anchors 80 enter the left ventricle 1080, the ventricular anchors 80 can pass through the chordae 110 and move behind the mitral valve leaflets 108, thereby capturing the leaflets 108. In some embodiments, the ventricular anchors 80 and/or other parts of the prosthesis 70 can push the chordae 110 and/or the mitral valve leaflets 108 outwards.

Thus, after release of the ventricular anchors 80, the delivery system 100 can then be repositioned as needed so that the ends of the left ventricular anchors 80 are at the same level of the free edge of the native mitral valve leaflets as shown in FIG. 27B. The delivery system 100 can also be positioned to be coaxial to the mitral annulus 106 if possible while still reducing contact with the left ventricular wall, the left atrial wall, and/or the annulus 106.

As shown above, in some embodiments, only the ventricular anchors 80 are released in the left atrium 1078 before the prosthesis 1010 is move to a position within, or below, the annulus. In some alternate embodiments, the distal end of the prosthesis 70 can be further expanded in the left atrium 1078, as shown in FIG. 27C. Thus, instead of the ventricular anchors 80 flipping and no portion of the prosthesis 70 body expanding, a portion of the prosthesis 70 can be exposed and allowed to expand in the left atrium 1078. This partially exposed prosthesis 70 can then be passed through the annulus 106 into the left ventricle 1080, such as shown in FIG. 27D. Further, the atrial anchors 82 can be exposed. This is an alternative methodology as compared to FIGS. 27A-B. In some embodiments, the entirety of the prosthesis 70 can be expanded within the left atrium 1078.

To facilitate passage through the annulus 106, the delivery system 100 can include a leader element (not shown) which passes through the annulus 106 prior to the prosthesis 10 passing through the annulus 106. For example, the leader element can include an expandable member, such as an expandable balloon, which can help maintain the shape, or expand, the annulus 106. The leader element can have a tapered or rounded shape (e.g., conical, frustoconical, semispherical) to facilitate positioning through and expansion of the annulus 106. In some embodiments, the delivery system 100 can include an engagement element (not shown) which can apply a force on the prosthesis 70 to force the prosthesis 70 through the annulus 106. For example, the engagement element can include an expandable member, such as an expandable balloon, positioned within or above the prosthesis 70. In some embodiments, the engagement element can include one or more tethers.

However, if only the ventricular anchors 80 are flipped, and no other expansion occurs such as shown in FIGS. 27A-B, the expansion shown in FIG. 27C can be skipped and the prosthesis can instead be partially expanded in the ventricle 1080 to the position shown in FIG. 27D. Thus, when the prosthesis 70 is in the proper location, the distal end can be allowed to expand to capture the leaflets 108. If the distal end is already expanded, such as from FIG. 27C, no more expansion may take place or the distal end can be further expanded.

Further, the PML and AML 108 can be captured, for example by adjusting the depth and angle of the prosthesis 70. FIG. 27E shows the position of the prosthesis 70 after capturing the leaflets 108. If a larger prosthesis diameter is needed to capture the leaflets 108, the elongate hollow member shaft 114 can be retracted until the desired diameter of the prosthesis 70 is achieved. Capture of the leaflets 108 can be confirmed through echo imaging. In some embodiments, a user can confirm that the prosthesis 70 is still in the appropriate depth and has not advanced into the left ventricle 1080. The position can be adjusted as needed.

In some embodiments, once the ventricular anchors 80 enter the left ventricle 1080 the system 100 can be pushed upwards (e.g., towards the left atrium 1078) to fully capture the leaflets 108 as shown in FIG. 27E. In some embodiments, the system 100 does not need to be pulled backwards to capture the leaflets 108. In some embodiments, systolic pressure can push the leaflets 108 upwards to be captured by the ventricular anchors 80. In some embodiments, a user can rotate the delivery system 100 and/or prosthesis 1010 prior to and/or while pulling the delivery system 100 backwards. In some instances, this can beneficially engage a greater number of chordae tendineae.

The delivery system 100 can be maneuvered to be coaxial and height relative to the mitral annulus 106, such as by translating or rotating the delivery system 100. As needed, the prosthesis 70 can be repositioned to capture the free edge of the native mitral valve leaflets 108. Once full engagement of the leaflets 108 is confirmed, the prosthesis 70 can be set perpendicular (or generally perpendicular) to the mitral annular plane. The tether 136 can continue to be released to continue expansion of the prosthesis 70.

Following, the nose cone 118 can be advanced distally until the first end 301 of the prosthesis 70 and the left atrial anchors 82 are exposed and the prosthesis 70 expanded as shown in FIG. 27F. The nose cone 118 can then be reversed in direction to relieve any tension on the delivery system 100. As discussed in detail above, the prosthesis 70 may still be connected to the delivery system 100 through the tether configuration. If the prosthesis 70 is determined to be in the correct position, the tethers can be released and the prosthesis 70 can be released from the delivery system 100.

In some embodiments, atrial anchors 82 may not be released from the system 10 until the ventricular anchors 80 have captured the leaflets 108. In some embodiments, atrial anchors 82 may be released from the system 10 prior to the ventricular anchors 80 capturing the leaflets 108. In some embodiments, the atrial anchors 82 can be released when the ventricular anchors 80 are super or intra annular and the expanded prosthesis 70 (either partially or fully expanded) can be translated through the mitral annulus 106.

After, the leaflet capture and positioning of the prosthesis 70 can be confirmed, along with the relatively perpendicular position with respect to the mitral annular plane. Proper positioning of the prosthesis 70 can be confirmed using TEE and fluoroscopic imaging.

Following, the delivery system 100 can be centralized within the prosthesis 70. The nose cone 118 can be translated to be flush with the outer elongate hollow member shaft 114. The delivery system 100 can then be retracted into the left atrium 1078 and removed.

This intra-super annulus release can have a number of advantageous. For example, this allows the ventricular anchors 80 to be properly aligned when contacting the chordae 110. If the ventricular anchors 80 were released in the left ventricle 1080, this could cause misalignment or damage to heart tissue, such as the leaflets 108 or chordae 110.

FIGS. 28A-B illustrate an alternate approach to releasing the prosthesis 70. As shown in FIG. 28A, the delivery system 100 can be translated into the left ventricle 1080 prior to release of the prosthesis 70. Thus, the ventricular end of the prosthesis 70, and thus the ventricular anchors 80, can be released and flipped partially, or fully within the left ventricle 1080 as shown in FIG. 28A upon proximal retraction of the outer elongate hollow member shaft 114. Accordingly, in some embodiments the anchors 80 can be released/flipped below the mitral annulus 106, and/or below the free edges of the leaflets 108. Further, the anchors 80 can be released above the papillary heads. Similar methodology as discussed above can then be used to properly position the prosthesis 70 and remove the delivery system 100 to deliver the prosthesis 70 into the position shown in FIG. 27F. In some embodiments, a waist of the prosthesis 70 can be even with the free edge of the leaflets 108 during release. In some embodiments, the ventricular anchors 80 may release in the ventricle 1080 without expansion of the prosthesis 70 body, such as discussed in detail above with respect to FIGS. 27A-B.

In any of the procedures described herein, a user can utilize rapid pacing at any step of the process. In some instances, this can facilitate positioning and/or anchoring of the prosthesis 1010 to native tissue.

From the foregoing description, it will be appreciated that an inventive product and approaches for implant delivery systems are disclosed. While several components, techniques and aspects have been described with a certain degree of particularity, it is manifest that many changes can be made in the specific designs, constructions and methodology herein above described without departing from the spirit and scope of this disclosure.

Certain features that are described in this disclosure in the context of separate implementations can also be implemented in combination in a single implementation. Conversely, various features that are described in the context of a single implementation can also be implemented in multiple implementations separately or in any suitable subcombination. Moreover, although features may be described above as acting in certain combinations, one or more features from a claimed combination can, in some cases, be excised from the combination, and the combination may be claimed as any subcombination or variation of any subcombination.

Moreover, while methods may be depicted in the drawings or described in the specification in a particular order, such methods need not be performed in the particular order shown or in sequential order, and that all methods need not be performed, to achieve desirable results. Other methods that are not depicted or described can be incorporated in the example methods and processes. For example, one or more additional methods can be performed before, after, simultaneously, or between any of the described methods. Further, the methods may be rearranged or reordered in other implementations. Also, the separation of various system components in the implementations described above should not be understood as requiring such separation in all implementations, and it should be understood that the described components and systems can generally be integrated together in a single product or packaged into multiple products. Additionally, other implementations are within the scope of this disclosure.

Conditional language, such as “can,” “could,” “might,” or “may,” unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include or do not include, certain features, elements, and/or steps. Thus, such conditional language is not generally intended to imply that features, elements, and/or steps are in any way required for one or more embodiments.

Conjunctive language such as the phrase “at least one of X, Y, and Z,” unless specifically stated otherwise, is otherwise understood with the context as used in general to convey that an item, term, etc. may be either X, Y, or Z. Thus, such conjunctive language is not generally intended to imply that certain embodiments require the presence of at least one of X, at least one of Y, and at least one of Z.

Language of degree used herein, such as the terms “approximately,” “about,” “generally,” and “substantially” as used herein represent a value, amount, or characteristic close to the stated value, amount, or characteristic that still performs a desired function or achieves a desired result. For example, the terms “approximately”, “about”, “generally,” and “substantially” may refer to an amount that is within less than or equal to 10% of, within less than or equal to 5% of, within less than or equal to 1% of, within less than or equal to 0.1% of, and within less than or equal to 0.01% of the stated amount. If the stated amount is 0 (e.g., none, having no), the above recited ranges can be specific ranges, and not within a particular % of the value. For example, within less than or equal to 10 wt./vol. % of, within less than or equal to 5 wt./vol. % of, within less than or equal to 1 wt./vol. % of, within less than or equal to 0.1 wt./vol. % of, and within less than or equal to 0.01 wt./vol. % of the stated amount.

Some embodiments have been described in connection with the accompanying drawings. The figures are drawn to scale, but such scale should not be limiting, since dimensions and proportions other than what are shown are contemplated and are within the scope of the disclosed inventions. Distances, angles, etc. are merely illustrative and do not necessarily bear an exact relationship to actual dimensions and layout of the devices illustrated. Components can be added, removed, and/or rearranged. Further, the disclosure herein of any particular feature, aspect, method, property, characteristic, quality, attribute, element, or the like in connection with various embodiments can be used in all other embodiments set forth herein. Additionally, it will be recognized that any methods described herein may be practiced using any device suitable for performing the recited steps.

While a number of embodiments and variations thereof have been described in detail, other modifications and methods of using the same will be apparent to those of skill in the art. Accordingly, it should be understood that various applications, modifications, materials, and substitutions can be made of equivalents without departing from the unique and inventive disclosure herein or the scope of the claims.

Claims

1. A delivery system for a replacement valve, the delivery system comprising: a tether configured to releasably hold a replacement valve;a torqueing manifold configured to retain a first end of the tether;an engagement pin configured to move from a locked position to an unlocked position, the engagement pin configured to releasably retain a second end of the tether;a manifold shaft having the torqueing manifold on a distal end of the manifold shaft, the torqueing manifold having at least one protrusion extending distally from a distal end of the torqueing manifold;a bearing rotatably retained within the torqueing manifold; anda pin lock shaft having a release plate located proximal of the bearing and located on a distal end of the pin lock shaft, wherein the pin lock shaft is configured to engage the engagement pin in the locked position and the unlocked position;wherein longitudinal translation of the engagement pin from the locked position to the unlocked position releases the second end of the tether and the replacement valve from the delivery system; andwherein rotational movement of the torqueing manifold with respect to the engagement pin is configured to crimp or uncrimp a portion of the replacement valve.
2. The delivery system of claim 1, wherein circumferential rotation of the manifold shaft with respect to the pin lock shaft is configured to crimp or uncrimp the portion of the replacement valve.
3. The delivery system of claim 1, wherein the engagement pin extends between the release plate and the bearing in the locked position, and wherein the second end of the tether is retained on the engagement pin between the release plate and the bearing in the locked position.
4. The delivery system of claim 1, wherein the manifold shaft is located within a lumen of the pin lock shaft, wherein the pin lock shaft is configured to longitudinally and rotationally translate with respect to the manifold shaft, and wherein proximal translation of the pin lock shaft releases the engagement pin from the bearing which releases the second end of the tether from the engagement pin.
5. The delivery system of claim 1, wherein the torqueing manifold comprises a plurality of distally extending protrusions extending around an outer circumference of the distal end of the torqueing manifold.
6. The delivery system of claim 1, wherein the engagement pin is generally L-shaped.
7. The delivery system of claim 1, further comprising the replacement valve, wherein the replacement valve is a replacement mitral valve.
8. The delivery system of claim 1, wherein the tether is configured to pass through an eyelet of the replacement valve.
9. A method of releasing a replacement valve from a delivery system, the method comprising: expanding the replacement valve from a compressed configuration to an expanded configuration, the replacement valve having a distal end and a proximal end, the replacement valve releasably attached to a manifold of the delivery system at a location distal to the replacement valve through at least one tether releasably retained on an engagement pin connected to the manifold in a locked position;rotating a manifold shaft located radially inwards of the replacement valve in a first direction with respect to a locking shaft, wherein the manifold shaft has the manifold on a distal end located distal to the replacement valve, wherein the at least one tether is connected to the manifold and the locking shaft, and wherein the manifold shaft is located within a lumen of the locking shaft, wherein the rotating the manifold shaft in the first direction loosens the at least one tether to uncrimp the distal end of the replacement valve; andproximally translating the engagement pin from the locked position to an unlocked position outside of the manifold, thereby releasing the at least one tether and the replacement valve.
10. The method of claim 9, wherein the expanding the replacement valve comprises: proximally translating an outer sheath to uncover the proximal end of the replacement valve; anddistally translating a nosecone to uncover the distal end of the replacement valve.
11. The method of claim 9, further comprising rotating the manifold shaft in a second direction opposite the first direction with respect to the locking shaft to crimp the distal end of the replacement valve.
12. The method of claim 11, further comprising proximally translating a nosecone to cover the distal end of the replacement valve when the replacement valve is crimped.
13. The method of claim 9, further comprising proximally translating the locking shaft with respect to the manifold shaft which proximally translates the engagement pin to the unlocked position.
14. The method of claim 9, wherein the replacement valve is releasably attached to the delivery system via a plurality of tethers connected to a plurality of engagement pins.
15. The method of claim 9, wherein the replacement valve is a replacement mitral valve.

INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

This application is a continuation of International Application No. PCT/US2019/014999, filed Jan. 24, 2019, designating the United States and published in English by the International Bureau on Aug. 1, 2019 as WO 2019/147846, which claims priority to U.S. Provisional App. No. 62/622,036, filed Jan. 25, 2018, the entirety of each of which is hereby incorporated by reference in its entirety.

US Referenced Citations (836)

Number	Name	Date	Kind
3657744	Ersek	Apr 1972	A
3671979	Moulopoulos	Jun 1972	A
3739402	Cooley et al.	Jun 1973	A
4056854	Boretos et al.	Nov 1977	A
4079468	Liotta et al.	Mar 1978	A
4204283	Bellhouse et al.	May 1980	A
4222126	Boretos et al.	Sep 1980	A
4265694	Boretos et al.	May 1981	A
4339831	Johnson	Jul 1982	A
4340977	Brownlee et al.	Jul 1982	A
4470157	Love	Sep 1984	A
4477930	Totten et al.	Oct 1984	A
4490859	Black et al.	Jan 1985	A
4553545	Maass et al.	Nov 1985	A
4655771	Wallsten	Apr 1987	A
4733665	Palmaz	Mar 1988	A
4776337	Palmaz	Oct 1988	A
4777951	Cribier et al.	Oct 1988	A
4865600	Carpentier et al.	Sep 1989	A
4994077	Dobben	Feb 1991	A
5197978	Hess	Mar 1993	A
5315996	Lundquist	May 1994	A
5326371	Love et al.	Jul 1994	A
5332402	Teitelbaum	Jul 1994	A
5368564	Savage	Nov 1994	A
5370685	Stevens	Dec 1994	A
5397355	Marin et al.	Mar 1995	A
5411552	Andersen et al.	May 1995	A
5415667	Frater	May 1995	A
5439446	Barry	Aug 1995	A
5439466	Kilejian	Aug 1995	A
5441483	Avitall	Aug 1995	A
5474563	Myler et al.	Dec 1995	A
5545214	Stevens	Aug 1996	A
5554185	Block et al.	Sep 1996	A
5573520	Schwartz et al.	Nov 1996	A
5575818	Pinchuk	Nov 1996	A
5607444	Lam	Mar 1997	A
5669919	Sanders et al.	Sep 1997	A
5693061	Pierce et al.	Dec 1997	A
5697382	Love et al.	Dec 1997	A
D390957	Fontaine	Feb 1998	S
5725519	Penner et al.	Mar 1998	A
5769812	Stevens et al.	Jun 1998	A
5782809	Umeno et al.	Jul 1998	A
5807398	Shaknovich	Sep 1998	A
5810873	Morales	Sep 1998	A
5840081	Andersen et al.	Nov 1998	A
5855601	Bessler et al.	Jan 1999	A
5868777	Lam	Feb 1999	A
5868782	Frantzen	Feb 1999	A
5879381	Moriuchi et al.	Mar 1999	A
5902334	Dwyer et al.	May 1999	A
5935108	Katoh et al.	Aug 1999	A
5957949	Leonhardt et al.	Sep 1999	A
5992000	Humphrey et al.	Nov 1999	A
6004328	Solar	Dec 1999	A
6015431	Thornton et al.	Jan 2000	A
6042606	Frantzen	Mar 2000	A
6053940	Wijay	Apr 2000	A
6086612	Jansen	Jul 2000	A
6113612	Swanson et al.	Sep 2000	A
6113631	Jansen	Sep 2000	A
6132458	Staehle et al.	Oct 2000	A
6152937	Peterson et al.	Nov 2000	A
6159237	Alt et al.	Dec 2000	A
6168614	Andersen et al.	Jan 2001	B1
6168616	Brown, III	Jan 2001	B1
6251093	Valley et al.	Jun 2001	B1
6280466	Kugler et al.	Aug 2001	B1
6306141	Jervis	Oct 2001	B1
6312465	Griffin et al.	Nov 2001	B1
6336938	Kavteladze et al.	Jan 2002	B1
6352543	Cole	Mar 2002	B1
6358277	Duran	Mar 2002	B1
6440164	DiMatteo et al.	Aug 2002	B1
6458153	Bailey et al.	Oct 2002	B1
6475237	Drasler et al.	Nov 2002	B2
6482228	Norred	Nov 2002	B1
6511491	Grudem et al.	Jan 2003	B2
6527800	McGuckin, Jr. et al.	Mar 2003	B1
6540778	Quiachon et al.	Apr 2003	B1
6540782	Snyders	Apr 2003	B1
6582462	Andersen et al.	Jun 2003	B1
6602281	Klein	Aug 2003	B1
6610088	Gabbay	Aug 2003	B1
6623518	Thompson et al.	Sep 2003	B2
6629534	St. Goar et al.	Oct 2003	B1
6641606	Ouriel et al.	Nov 2003	B2
6652578	Bailey et al.	Nov 2003	B2
6664058	Kumar et al.	Dec 2003	B2
D484979	Fontaine	Jan 2004	S
6676698	McGuckin, Jr. et al.	Jan 2004	B2
6682537	Ouriel et al.	Jan 2004	B2
6695878	McGuckin, Jr. et al.	Feb 2004	B2
6712836	Berg et al.	Mar 2004	B1
6716207	Farnholtz	Apr 2004	B2
6729356	Baker et al.	May 2004	B1
6730118	Spenser et al.	May 2004	B2
6746422	Noriega et al.	Jun 2004	B1
6749560	Konstorum et al.	Jun 2004	B1
6764505	Hossainy et al.	Jul 2004	B1
6767362	Schreck	Jul 2004	B2
6780200	Jansen	Aug 2004	B2
6790229	Berreklouw	Sep 2004	B1
6790230	Beyersdorf et al.	Sep 2004	B2
6814746	Thompson et al.	Nov 2004	B2
6846325	Liddicoat	Jan 2005	B2
6858034	Hijlkema et al.	Feb 2005	B1
6875231	Anduiza et al.	Apr 2005	B2
6893460	Spenser et al.	May 2005	B2
6908481	Cribier	Jun 2005	B2
6926732	Derus et al.	Aug 2005	B2
6929660	Ainsworth et al.	Aug 2005	B1
6936058	Forde et al.	Aug 2005	B2
6974464	Quijano et al.	Dec 2005	B2
7018401	Hyodoh et al.	Mar 2006	B1
7018406	Seguin et al.	Mar 2006	B2
7044962	Elliott	May 2006	B2
7087088	Berg et al.	Aug 2006	B2
7147660	Chobotov et al.	Dec 2006	B2
7147661	Chobotov et al.	Dec 2006	B2
7153322	Alt	Dec 2006	B2
7186265	Sharkawy et al.	Mar 2007	B2
7192440	Andreas et al.	Mar 2007	B2
7198646	Figulla et al.	Apr 2007	B2
7201772	Schwammenthal et al.	Apr 2007	B2
D553747	Fliedner	Oct 2007	S
7276078	Spenser et al.	Oct 2007	B2
7329278	Seguin et al.	Feb 2008	B2
7329279	Haug et al.	Feb 2008	B2
7331992	Randall et al.	Feb 2008	B2
7354450	Bicek et al.	Apr 2008	B2
7381198	Noriega et al.	Jun 2008	B2
7381219	Salahieh et al.	Jun 2008	B2
7393360	Spenser et al.	Jul 2008	B2
7402168	Sanderson et al.	Jul 2008	B2
7429269	Schwammenthal et al.	Sep 2008	B2
7442204	Schwammenthal et al.	Oct 2008	B2
7445631	Salahieh et al.	Nov 2008	B2
7462191	Spenser et al.	Dec 2008	B2
7510575	Spenser et al.	Mar 2009	B2
7524330	Berreklouw	Apr 2009	B2
7553324	Andreas et al.	Jun 2009	B2
7569071	Haverkost et al.	Aug 2009	B2
7585321	Cribier	Sep 2009	B2
7608114	Levine et al.	Oct 2009	B2
7615072	Rust et al.	Nov 2009	B2
7618446	Andersen et al.	Nov 2009	B2
7621948	Herrmann et al.	Nov 2009	B2
7628805	Spenser et al.	Dec 2009	B2
7632298	Hijlkema et al.	Dec 2009	B2
7637902	Eversull et al.	Dec 2009	B2
7658759	Case et al.	Feb 2010	B2
7708775	Rowe et al.	May 2010	B2
7748389	Salahieh et al.	Jul 2010	B2
7749266	Forster et al.	Jul 2010	B2
7753949	Lamphere et al.	Jul 2010	B2
D622387	Igaki	Aug 2010	S
D622388	Igaki	Aug 2010	S
7771463	Ton et al.	Aug 2010	B2
7785360	Freitag	Aug 2010	B2
7803185	Gabbay	Sep 2010	B2
7806917	Xiao	Oct 2010	B2
7806919	Bloom et al.	Oct 2010	B2
7815589	Meade et al.	Oct 2010	B2
7815673	Bloom et al.	Oct 2010	B2
7824443	Salahieh et al.	Nov 2010	B2
7892281	Seguin et al.	Feb 2011	B2
D635261	Rossi	Mar 2011	S
D635262	Rossi	Mar 2011	S
7914466	Davis et al.	Mar 2011	B2
7914569	Nguyen et al.	Mar 2011	B2
7918819	Karmarkar et al.	Apr 2011	B2
7947075	Goetz et al.	May 2011	B2
7959672	Salahieh et al.	Jun 2011	B2
7972378	Tabor et al.	Jul 2011	B2
7981151	Rowe	Jul 2011	B2
7988724	Salahieh et al.	Aug 2011	B2
7993392	Righini et al.	Aug 2011	B2
8016877	Seguin et al.	Sep 2011	B2
8048153	Salahieh et al.	Nov 2011	B2
8052750	Tuval et al.	Nov 2011	B2
8057538	Bergin et al.	Nov 2011	B2
8070799	Righini et al.	Dec 2011	B2
8070800	Lock et al.	Dec 2011	B2
8070802	Lamphere et al.	Dec 2011	B2
8075615	Eberhardt et al.	Dec 2011	B2
8080054	Rowe	Dec 2011	B2
8092444	Lentz et al.	Jan 2012	B2
8092520	Quadri	Jan 2012	B2
8109996	Stacchino et al.	Feb 2012	B2
8118866	Herrmann et al.	Feb 2012	B2
8136218	Millwee et al.	Mar 2012	B2
8137398	Tuval et al.	Mar 2012	B2
8157852	Bloom et al.	Apr 2012	B2
8167926	Hartley et al.	May 2012	B2
8167932	Bourang et al.	May 2012	B2
8167934	Styrc et al.	May 2012	B2
8177799	Orban, III	May 2012	B2
8182528	Salahieh et al.	May 2012	B2
8182530	Huber	May 2012	B2
8197528	Colgan et al.	Jun 2012	B2
8216261	Solem	Jul 2012	B2
8216301	Bonhoeffer et al.	Jul 2012	B2
8219229	Cao et al.	Jul 2012	B2
8220121	Hendriksen et al.	Jul 2012	B2
8221482	Cottone et al.	Jul 2012	B2
8221493	Boyle et al.	Jul 2012	B2
8226710	Nguyen et al.	Jul 2012	B2
D665079	Zago	Aug 2012	S
D665080	Zago	Aug 2012	S
8236045	Benichou et al.	Aug 2012	B2
8241350	Randall et al.	Aug 2012	B2
8246675	Zegdi	Aug 2012	B2
8246678	Salahieh et al.	Aug 2012	B2
8252051	Chau et al.	Aug 2012	B2
8252052	Salahieh et al.	Aug 2012	B2
8262563	Bakos et al.	Sep 2012	B2
8287584	Salahieh et al.	Oct 2012	B2
8303653	Bonhoeffer et al.	Nov 2012	B2
8308798	Pintor et al.	Nov 2012	B2
8313525	Tuval et al.	Nov 2012	B2
8317854	Ryan et al.	Nov 2012	B1
8323241	Salahieh et al.	Dec 2012	B2
8323335	Rowe et al.	Dec 2012	B2
8348995	Tuval et al.	Jan 2013	B2
8353953	Giannetti et al.	Jan 2013	B2
8361137	Perouse	Jan 2013	B2
8403982	Giannetti et al.	Mar 2013	B2
8403983	Quadri et al.	Mar 2013	B2
8414644	Quadri et al.	Apr 2013	B2
8414645	Dwork et al.	Apr 2013	B2
8425593	Braido et al.	Apr 2013	B2
8444689	Zhang	May 2013	B2
8449599	Chau et al.	May 2013	B2
8449625	Campbell et al.	May 2013	B2
8454685	Hariton et al.	Jun 2013	B2
8460365	Haverkost et al.	Jun 2013	B2
8460368	Taylor et al.	Jun 2013	B2
8465541	Dwork	Jun 2013	B2
8470020	Schaeffer et al.	Jun 2013	B2
8470023	Eidenschink et al.	Jun 2013	B2
8470025	Lenihan et al.	Jun 2013	B2
8470028	Thornton et al.	Jun 2013	B2
8475521	Suri et al.	Jul 2013	B2
8475522	Jimenez et al.	Jul 2013	B2
8475523	Duffy	Jul 2013	B2
8479380	Malewicz et al.	Jul 2013	B2
8486137	Suri et al.	Jul 2013	B2
8491650	Wiemeyer et al.	Jul 2013	B2
8500733	Watson	Aug 2013	B2
8500785	Gunderson	Aug 2013	B2
8500798	Rowe et al.	Aug 2013	B2
8511244	Holecek et al.	Aug 2013	B2
8512401	Murray, III et al.	Aug 2013	B2
8518096	Nelson	Aug 2013	B2
8518106	Duffy et al.	Aug 2013	B2
8535368	Headley, Jr. et al.	Sep 2013	B2
8562663	Mearns et al.	Oct 2013	B2
8568472	Marchand et al.	Oct 2013	B2
8579963	Tabor	Nov 2013	B2
8579964	Lane et al.	Nov 2013	B2
8579965	Bonhoeffer et al.	Nov 2013	B2
8579966	Seguin et al.	Nov 2013	B2
8584849	McCaffrey	Nov 2013	B2
8585749	Shelso	Nov 2013	B2
8585755	Chau et al.	Nov 2013	B2
8585756	Bonhoeffer et al.	Nov 2013	B2
8591460	Wilson et al.	Nov 2013	B2
8591570	Revuelta et al.	Nov 2013	B2
8597348	Rowe et al.	Dec 2013	B2
8617236	Paul et al.	Dec 2013	B2
8623075	Murray, III et al.	Jan 2014	B2
8640521	Righini et al.	Feb 2014	B2
8641757	Pintor et al.	Feb 2014	B2
8647381	Essinger et al.	Feb 2014	B2
8652145	Maimon et al.	Feb 2014	B2
8652201	Oberti et al.	Feb 2014	B2
8652202	Alon et al.	Feb 2014	B2
8652203	Quadri et al.	Feb 2014	B2
8668733	Haug et al.	Mar 2014	B2
8672992	Or	Mar 2014	B2
8673000	Tabor et al.	Mar 2014	B2
8679174	Ottma et al.	Mar 2014	B2
8679404	Liburd et al.	Mar 2014	B2
8685084	Rolando et al.	Apr 2014	B2
8685086	Navia et al.	Apr 2014	B2
8707957	Callister et al.	Apr 2014	B2
8721707	Boucher et al.	May 2014	B2
8721708	Seguin et al.	May 2014	B2
8721713	Tower et al.	May 2014	B2
8721714	Kelley	May 2014	B2
8728154	Alkhatib	May 2014	B2
8728155	Montorfano et al.	May 2014	B2
8740974	Lambrecht et al.	Jun 2014	B2
8740976	Tran et al.	Jun 2014	B2
8747458	Tuval et al.	Jun 2014	B2
8747459	Nguyen et al.	Jun 2014	B2
8747460	Tuval et al.	Jun 2014	B2
8753384	Leanna	Jun 2014	B2
8758432	Solem	Jun 2014	B2
8764814	Solem	Jul 2014	B2
8764818	Gregg	Jul 2014	B2
8771338	Schaeffer et al.	Jul 2014	B2
8771344	Tran et al.	Jul 2014	B2
8771345	Tuval et al.	Jul 2014	B2
8771346	Tuval et al.	Jul 2014	B2
8778019	Knippel et al.	Jul 2014	B2
8778020	Gregg et al.	Jul 2014	B2
8784337	Voeller et al.	Jul 2014	B2
8784478	Tuval et al.	Jul 2014	B2
8784481	Alkhatib et al.	Jul 2014	B2
8790387	Nguyen et al.	Jul 2014	B2
8795355	Alkhatib	Aug 2014	B2
8795356	Quadri et al.	Aug 2014	B2
8795357	Yohanan et al.	Aug 2014	B2
8808356	Braido et al.	Aug 2014	B2
8814931	Wang et al.	Aug 2014	B2
8828078	Salahieh et al.	Sep 2014	B2
8828079	Thielen et al.	Sep 2014	B2
8834564	Tuval et al.	Sep 2014	B2
8845718	Tuval et al.	Sep 2014	B2
8852267	Cattaneo	Oct 2014	B2
8858620	Salahieh et al.	Oct 2014	B2
8870790	Davis et al.	Oct 2014	B2
8870947	Shaw	Oct 2014	B2
8870948	Erzberger et al.	Oct 2014	B1
8870950	Hacohen	Oct 2014	B2
8876883	Rust	Nov 2014	B2
8876892	Tran et al.	Nov 2014	B2
8876893	Dwork et al.	Nov 2014	B2
8876894	Tuval et al.	Nov 2014	B2
8876895	Tuval et al.	Nov 2014	B2
8894703	Salahieh et al.	Nov 2014	B2
8900163	Jacobsen et al.	Dec 2014	B2
8911455	Quadri et al.	Dec 2014	B2
8915865	Jacobsen et al.	Dec 2014	B2
8926692	Dwork	Jan 2015	B2
8926693	Duffy et al.	Jan 2015	B2
8926694	Costello	Jan 2015	B2
8939960	Rosenman et al.	Jan 2015	B2
8945146	Steingisser et al.	Feb 2015	B2
8945209	Bonyuet et al.	Feb 2015	B2
8951243	Crisostomo et al.	Feb 2015	B2
8951299	Paul et al.	Feb 2015	B2
8961583	Hojeibane et al.	Feb 2015	B2
8961593	Bonhoeffer et al.	Feb 2015	B2
8961595	Alkhatib	Feb 2015	B2
8974524	Yeung et al.	Mar 2015	B2
8979922	Jayasinghe et al.	Mar 2015	B2
8986372	Murry, III et al.	Mar 2015	B2
8986375	Garde et al.	Mar 2015	B2
8992608	Haug et al.	Mar 2015	B2
8998979	Seguin et al.	Apr 2015	B2
8998980	Shipley et al.	Apr 2015	B2
9005270	Perkins et al.	Apr 2015	B2
9005273	Salahieh et al.	Apr 2015	B2
9005278	Pintor et al.	Apr 2015	B2
9011521	Haug et al.	Apr 2015	B2
9011523	Seguin	Apr 2015	B2
9011524	Eberhardt	Apr 2015	B2
9028545	Taylor	May 2015	B2
9029418	Dove et al.	May 2015	B2
9034032	McLean et al.	May 2015	B2
9034033	McLean et al.	May 2015	B2
9039676	Klima	May 2015	B2
9039757	McLean et al.	May 2015	B2
9055937	Rowe et al.	Jun 2015	B2
9061119	Le et al.	Jun 2015	B2
9066801	Kovalsky et al.	Jun 2015	B2
9078749	Lutter et al.	Jul 2015	B2
9078751	Naor	Jul 2015	B2
9084676	Chau et al.	Jul 2015	B2
9084694	Goodin et al.	Jul 2015	B2
9125738	Figulla et al.	Sep 2015	B2
9138312	Tuval et al.	Sep 2015	B2
9155619	Liu et al.	Oct 2015	B2
9161834	Taylor et al.	Oct 2015	B2
9168129	Valdez et al.	Oct 2015	B2
9173737	Hill et al.	Nov 2015	B2
9173738	Murray, III et al.	Nov 2015	B2
9180004	Alkhatib	Nov 2015	B2
9186249	Rolando et al.	Nov 2015	B2
9192469	Mearns et al.	Nov 2015	B2
9216056	Datta et al.	Dec 2015	B2
9220594	Braido et al.	Dec 2015	B2
9241790	Lane et al.	Jan 2016	B2
9241794	Braido et al.	Jan 2016	B2
9248014	Lane et al.	Feb 2016	B2
9271856	Duffy et al.	Mar 2016	B2
9277990	Klima et al.	Mar 2016	B2
9277993	Gamarra et al.	Mar 2016	B2
9289291	Gorman, III et al.	Mar 2016	B2
9289296	Braido et al.	Mar 2016	B2
9295551	Straubinger et al.	Mar 2016	B2
9308105	Carlson et al.	Apr 2016	B2
9326815	Watson	May 2016	B2
9326871	Schaeffer et al.	May 2016	B2
9331328	Eberhardt et al.	May 2016	B2
9339382	Tabor et al.	May 2016	B2
9351831	Braido et al.	May 2016	B2
9364321	Alkhatib et al.	Jun 2016	B2
9370423	Ryan	Jun 2016	B2
9375312	Weber	Jun 2016	B2
9414915	Lombardi et al.	Aug 2016	B2
9445897	Bishop et al.	Sep 2016	B2
9456877	Weitzner et al.	Oct 2016	B2
9504564	Nguyen et al.	Nov 2016	B2
9532870	Cooper et al.	Jan 2017	B2
9572662	Morriss et al.	Feb 2017	B2
9579193	Rafiee	Feb 2017	B2
9579196	Morriss et al.	Feb 2017	B2
9585751	Morriss et al.	Mar 2017	B2
9592120	Tuval et al.	Mar 2017	B2
9597181	Christianson et al.	Mar 2017	B2
9597182	Straubinger et al.	Mar 2017	B2
9629718	Gloss et al.	Apr 2017	B2
9675452	Valdez et al.	Jun 2017	B2
9681968	Goetz et al.	Jun 2017	B2
9700329	Metzger et al.	Jul 2017	B2
9700411	Klima et al.	Jul 2017	B2
9717593	Alkhatib et al.	Aug 2017	B2
9737398	Bruchman et al.	Aug 2017	B2
9737400	Fish et al.	Aug 2017	B2
9750606	Ganesan et al.	Sep 2017	B2
9763780	Morriss et al.	Sep 2017	B2
9770329	Lane et al.	Sep 2017	B2
9775705	Ottma et al.	Oct 2017	B2
9788945	Ottma et al.	Oct 2017	B2
9795479	Lim et al.	Oct 2017	B2
9833313	Board et al.	Dec 2017	B2
9833315	Vidlund et al.	Dec 2017	B2
9839511	Ma et al.	Dec 2017	B2
9861473	Lafontaine	Jan 2018	B2
9861476	Salahieh et al.	Jan 2018	B2
9861477	Backus et al.	Jan 2018	B2
9867695	Stacchino et al.	Jan 2018	B2
9867697	Alkhatib et al.	Jan 2018	B2
9867698	Kovalsky et al.	Jan 2018	B2
9877830	Lim et al.	Jan 2018	B2
9889002	Bonhoeffer et al.	Feb 2018	B2
9889029	Li et al.	Feb 2018	B2
9895225	Rolando et al.	Feb 2018	B2
9901443	Morriss et al.	Feb 2018	B2
9907681	Tobis et al.	Mar 2018	B2
9913714	Tuval et al.	Mar 2018	B2
9925045	Creaven et al.	Mar 2018	B2
9931232	Gunderson et al.	Apr 2018	B2
9962260	Krans et al.	May 2018	B2
9974651	Hariton et al.	May 2018	B2
9987463	Guo et al.	Jun 2018	B2
10010418	Marchand et al.	Jul 2018	B2
10039642	Hillukka	Aug 2018	B2
10058420	Levi	Aug 2018	B2
10058422	Braido	Aug 2018	B2
10064718	Keidar	Sep 2018	B2
10070954	Braido et al.	Sep 2018	B2
10080656	Schweich, Jr. et al.	Sep 2018	B2
10092400	Jimenez et al.	Oct 2018	B2
10098736	Carmi et al.	Oct 2018	B2
10117744	Ratz et al.	Nov 2018	B2
10123871	Liu et al.	Nov 2018	B2
10130467	Braido et al.	Nov 2018	B2
10130470	Thomas et al.	Nov 2018	B2
10149758	Racchini et al.	Dec 2018	B2
10149760	Johnson et al.	Dec 2018	B2
10154921	Stante et al.	Dec 2018	B2
10172732	Murphy et al.	Jan 2019	B2
10179044	Ratz et al.	Jan 2019	B2
10188536	Lombardi et al.	Jan 2019	B2
10201417	Lin et al.	Feb 2019	B2
10213301	Ganesan et al.	Feb 2019	B2
10226309	Ho et al.	Mar 2019	B2
10231827	Mulvihill	Mar 2019	B2
20010007956	Letac et al.	Jul 2001	A1
20010047200	White et al.	Nov 2001	A1
20020016623	Kula et al.	Feb 2002	A1
20020032481	Gabbay	Mar 2002	A1
20020045929	Diaz	Apr 2002	A1
20020052644	Shaolian et al.	May 2002	A1
20020111619	Keast et al.	Aug 2002	A1
20030069522	Jacobsen et al.	Apr 2003	A1
20030105517	White et al.	Jun 2003	A1
20030120333	Ouriel et al.	Jun 2003	A1
20030130729	Paniagua et al.	Jul 2003	A1
20030176914	Rabkin et al.	Sep 2003	A1
20030199971	Tower et al.	Oct 2003	A1
20030220683	Minasian et al.	Nov 2003	A1
20040117009	Cali et al.	Jun 2004	A1
20040133273	Cox	Jul 2004	A1
20040186561	McGuckin et al.	Sep 2004	A1
20040210307	Khairkhahan	Oct 2004	A1
20040215325	Penn et al.	Oct 2004	A1
20040225353	McGuckin et al.	Nov 2004	A1
20040236411	Sarac et al.	Nov 2004	A1
20040243230	Navia et al.	Dec 2004	A1
20050033398	Seguin	Feb 2005	A1
20050075727	Wheatley	Apr 2005	A1
20050090887	Pryor	Apr 2005	A1
20050096738	Cali et al.	May 2005	A1
20050107872	Mensah et al.	May 2005	A1
20050137682	Justino	Jun 2005	A1
20050137686	Salahieh et al.	Jun 2005	A1
20050137687	Salahieh et al.	Jun 2005	A1
20050137691	Salahieh et al.	Jun 2005	A1
20050159811	Lane	Jul 2005	A1
20050177131	Lentz et al.	Aug 2005	A1
20050182486	Gabbay	Aug 2005	A1
20050216079	MaCoviak	Sep 2005	A1
20050234546	Nugent et al.	Oct 2005	A1
20050283231	Haug et al.	Dec 2005	A1
20060020247	Kagan et al.	Jan 2006	A1
20060020327	Lashinski et al.	Jan 2006	A1
20060052867	Revuelta et al.	Mar 2006	A1
20060058872	Salahieh et al.	Mar 2006	A1
20060095115	Bladillah et al.	May 2006	A1
20060100687	Fahey et al.	May 2006	A1
20060100695	Peacock et al.	May 2006	A1
20060116625	Renati et al.	Jun 2006	A1
20060173537	Yang et al.	Aug 2006	A1
20060195183	Navia et al.	Aug 2006	A1
20060212110	Osborne et al.	Sep 2006	A1
20060224232	Chobotov	Oct 2006	A1
20060241564	Corcoran et al.	Oct 2006	A1
20060241745	Solem	Oct 2006	A1
20060259135	Navia et al.	Nov 2006	A1
20060293745	Carpentier et al.	Dec 2006	A1
20070010876	Salahieh et al.	Jan 2007	A1
20070043435	Seguin et al.	Feb 2007	A1
20070050021	Johnson	Mar 2007	A1
20070100432	Case et al.	May 2007	A1
20070129794	Realyvasquez	Jun 2007	A1
20070142906	Figulla et al.	Jun 2007	A1
20070213813	Von Segesser et al.	Sep 2007	A1
20070219620	Eells et al.	Sep 2007	A1
20070250151	Pereira	Oct 2007	A1
20070255394	Ryan	Nov 2007	A1
20070293940	Schaeffer et al.	Dec 2007	A1
20080009934	Schneider et al.	Jan 2008	A1
20080021546	Patz et al.	Jan 2008	A1
20080082164	Friedman	Apr 2008	A1
20080082165	Wilson et al.	Apr 2008	A1
20080097571	Denison et al.	Apr 2008	A1
20080097581	Shanley	Apr 2008	A1
20080147179	Cai et al.	Jun 2008	A1
20080147183	Styrc	Jun 2008	A1
20080161911	Revuelta et al.	Jul 2008	A1
20080177373	Huang et al.	Jul 2008	A1
20080177381	Navia et al.	Jul 2008	A1
20080183273	Mesana et al.	Jul 2008	A1
20080208307	Ben-Muvhar et al.	Aug 2008	A1
20080208327	Rowe	Aug 2008	A1
20080208328	Antocci et al.	Aug 2008	A1
20080234799	Acosta et al.	Sep 2008	A1
20080243233	Ben-Muvhar et al.	Oct 2008	A1
20080319526	Hill et al.	Dec 2008	A1
20090005863	Goetz et al.	Jan 2009	A1
20090082844	Zacharias et al.	Mar 2009	A1
20090082847	Zacharias et al.	Mar 2009	A1
20090088832	Chew et al.	Apr 2009	A1
20090118810	Klein et al.	May 2009	A1
20090125096	Chu et al.	May 2009	A1
20090138079	Tuval et al.	May 2009	A1
20090149946	Dixon	Jun 2009	A1
20090171438	Chuter et al.	Jul 2009	A1
20090171456	Kveen et al.	Jul 2009	A1
20090182407	Leanna et al.	Jul 2009	A1
20090182413	Burkart et al.	Jul 2009	A1
20090188964	Orlov	Jul 2009	A1
20090270972	Lane	Oct 2009	A1
20090276027	Glynn	Nov 2009	A1
20090276040	Rowe et al.	Nov 2009	A1
20090281618	Hill et al.	Nov 2009	A1
20090287296	Manasse	Nov 2009	A1
20090292350	Eberhardt et al.	Nov 2009	A1
20090306768	Quadri	Dec 2009	A1
20090312832	Delap	Dec 2009	A1
20100114299	Ben Muvhar et al.	May 2010	A1
20100114305	Kang et al.	May 2010	A1
20100191326	Alkhatib	Jul 2010	A1
20100217382	Chau et al.	Aug 2010	A1
20100249894	Oba et al.	Sep 2010	A1
20100249911	Alkhatib	Sep 2010	A1
20100256723	Murray	Oct 2010	A1
20100305685	Millwee et al.	Dec 2010	A1
20110004296	Lutter et al.	Jan 2011	A1
20110029067	McGuckin, Jr. et al.	Feb 2011	A1
20110208297	Tuval et al.	Aug 2011	A1
20110208298	Tuval et al.	Aug 2011	A1
20110224785	Hacohen	Sep 2011	A1
20110264196	Savage et al.	Oct 2011	A1
20110264198	Murray, III et al.	Oct 2011	A1
20110288626	Straubinger et al.	Nov 2011	A1
20110313515	Quadri et al.	Dec 2011	A1
20120022639	Hacohen et al.	Jan 2012	A1
20120035702	Horvath et al.	Feb 2012	A1
20120041550	Salahieh et al.	Feb 2012	A1
20120059454	Millwee et al.	Mar 2012	A1
20120078360	Rafiee	Mar 2012	A1
20120101571	Thambar et al.	Apr 2012	A1
20120101572	Kovalsky et al.	Apr 2012	A1
20120123529	Levi et al.	May 2012	A1
20120215303	Quadri et al.	Aug 2012	A1
20120259405	Weber et al.	Oct 2012	A1
20120271398	Essinger et al.	Oct 2012	A1
20120290062	McNamara et al.	Nov 2012	A1
20120310328	Olson et al.	Dec 2012	A1
20130006294	Kashkarov et al.	Jan 2013	A1
20130030520	Lee et al.	Jan 2013	A1
20130035759	Gross et al.	Feb 2013	A1
20130053950	Rowe et al.	Feb 2013	A1
20130116705	Salahieh et al.	May 2013	A1
20130131788	Quadri et al.	May 2013	A1
20130144375	Giasolli et al.	Jun 2013	A1
20130144378	Quadri et al.	Jun 2013	A1
20130172983	Clerc et al.	Jul 2013	A1
20130190861	Chau et al.	Jul 2013	A1
20130211508	Lane et al.	Aug 2013	A1
20130253635	Straubinger et al.	Sep 2013	A1
20130253642	Brecker	Sep 2013	A1
20130296718	Ranganathan et al.	Nov 2013	A1
20130310923	Kheradvar	Nov 2013	A1
20130310928	Morriss et al.	Nov 2013	A1
20130331929	Mitra et al.	Dec 2013	A1
20130338766	Hastings et al.	Dec 2013	A1
20130345786	Behan	Dec 2013	A1
20140005764	Schroeder	Jan 2014	A1
20140018912	Delaloye et al.	Jan 2014	A1
20140025163	Padala et al.	Jan 2014	A1
20140046427	Michalak	Feb 2014	A1
20140052237	Lane et al.	Feb 2014	A1
20140052242	Revuelta et al.	Feb 2014	A1
20140058502	Marchand et al.	Feb 2014	A1
20140067037	Fargahi	Mar 2014	A1
20140067054	Chau et al.	Mar 2014	A1
20140088565	Vongphakdy et al.	Mar 2014	A1
20140088685	Yevzlin et al.	Mar 2014	A1
20140100651	Kheradvar et al.	Apr 2014	A1
20140100653	Savage et al.	Apr 2014	A1
20140128969	Hill et al.	May 2014	A1
20140155990	Nyuli et al.	Jun 2014	A1
20140163668	Rafiee	Jun 2014	A1
20140172077	Bruchman et al.	Jun 2014	A1
20140172083	Bruchman et al.	Jun 2014	A1
20140194981	Menk et al.	Jul 2014	A1
20140207231	Hacohen et al.	Jul 2014	A1
20140214154	Nguyen et al.	Jul 2014	A1
20140214155	Kelley	Jul 2014	A1
20140214160	Naor	Jul 2014	A1
20140215791	Soundararajan et al.	Aug 2014	A1
20140222136	Geist et al.	Aug 2014	A1
20140222139	Nguyen et al.	Aug 2014	A1
20140222142	Kovalsky et al.	Aug 2014	A1
20140230515	Tuval et al.	Aug 2014	A1
20140236288	Lambrecht et al.	Aug 2014	A1
20140243957	Wang et al.	Aug 2014	A1
20140257467	Lane et al.	Sep 2014	A1
20140276395	Wilson et al.	Sep 2014	A1
20140277390	Ratz et al.	Sep 2014	A1
20140277402	Essinger et al.	Sep 2014	A1
20140277422	Ratz et al.	Sep 2014	A1
20140277427	Ratz et al.	Sep 2014	A1
20140296973	Bergheim et al.	Oct 2014	A1
20140296975	Tegels et al.	Oct 2014	A1
20140303719	Cox et al.	Oct 2014	A1
20140309728	Dehdashtian et al.	Oct 2014	A1
20140309732	Solem	Oct 2014	A1
20140324160	Benichou et al.	Oct 2014	A1
20140324162	Knippel et al.	Oct 2014	A1
20140324164	Gross et al.	Oct 2014	A1
20140330368	Gloss et al.	Nov 2014	A1
20140330371	Gloss et al.	Nov 2014	A1
20140330372	Weston et al.	Nov 2014	A1
20140331475	Duffy et al.	Nov 2014	A1
20140336754	Gurskis et al.	Nov 2014	A1
20140343669	Lane et al.	Nov 2014	A1
20140343670	Bakis	Nov 2014	A1
20140343671	Yohanan et al.	Nov 2014	A1
20140350663	Braido et al.	Nov 2014	A1
20140350666	Righini	Nov 2014	A1
20140350668	Delaloye et al.	Nov 2014	A1
20140358221	Ho et al.	Dec 2014	A1
20140358223	Rafiee et al.	Dec 2014	A1
20140364939	Deshmukh et al.	Dec 2014	A1
20140364943	Conklin	Dec 2014	A1
20140371842	Marquez et al.	Dec 2014	A1
20140371844	Dale et al.	Dec 2014	A1
20140371847	Madrid et al.	Dec 2014	A1
20140371848	Murray, III et al.	Dec 2014	A1
20140379067	Nguyen et al.	Dec 2014	A1
20140379068	Thielen et al.	Dec 2014	A1
20140379077	Tuval et al.	Dec 2014	A1
20150005863	Para	Jan 2015	A1
20150005873	Chang et al.	Jan 2015	A1
20150012085	Salahieh et al.	Jan 2015	A1
20150018938	Von Segesser et al.	Jan 2015	A1
20150018944	O'Connell et al.	Jan 2015	A1
20150039083	Rafiee	Feb 2015	A1
20150045880	Hacohen	Feb 2015	A1
20150099997	Cabiri	Apr 2015	A1
20150119974	Rothstein	Apr 2015	A1
20150127094	Salahieh et al.	May 2015	A1
20150142100	Morriss et al.	May 2015	A1
20150142103	Vidlund	May 2015	A1
20150148731	McNamara et al.	May 2015	A1
20150148815	Steingisser et al.	May 2015	A1
20150157457	Hacohen	Jun 2015	A1
20150157458	Thambar et al.	Jun 2015	A1
20150173897	Raanani et al.	Jun 2015	A1
20150196390	Ma et al.	Jul 2015	A1
20150202044	Chau et al.	Jul 2015	A1
20150209141	Braido et al.	Jul 2015	A1
20150238315	Rabito et al.	Aug 2015	A1
20150238336	Johnson et al.	Aug 2015	A1
20150272737	Dale et al.	Oct 2015	A1
20150282964	Beard et al.	Oct 2015	A1
20150297346	Duffy et al.	Oct 2015	A1
20150328000	Ratz et al.	Nov 2015	A1
20150328001	McLean et al.	Nov 2015	A1
20150328002	McLean et al.	Nov 2015	A1
20150335424	McLean et al.	Nov 2015	A1
20150342736	Rabito et al.	Dec 2015	A1
20150351906	Hammer et al.	Dec 2015	A1
20150359629	Ganesan et al.	Dec 2015	A1
20160000591	Lei et al.	Jan 2016	A1
20160030169	Shahriari	Feb 2016	A1
20160030171	Quijano et al.	Feb 2016	A1
20160038281	Delaloye et al.	Feb 2016	A1
20160074160	Christianson et al.	Mar 2016	A1
20160100885	Datta et al.	Apr 2016	A1
20160113765	Ganesan et al.	Apr 2016	A1
20160113768	Ganesan et al.	Apr 2016	A1
20160135951	Salahieh et al.	May 2016	A1
20160143732	Glimsdale	May 2016	A1
20160158010	Lim et al.	Jun 2016	A1
20160166383	Lim et al.	Jun 2016	A1
20160184097	Lim et al.	Jun 2016	A1
20160199206	Lim et al.	Jul 2016	A1
20160213473	Hacohen et al.	Jul 2016	A1
20160235525	Rothstein et al.	Aug 2016	A1
20160270935	Rasmussen et al.	Sep 2016	A1
20160278918	Ibeling	Sep 2016	A1
20160279386	Dale et al.	Sep 2016	A1
20160310267	Zeng et al.	Oct 2016	A1
20160317301	Quadri et al.	Nov 2016	A1
20160346513	Swaney	Dec 2016	A1
20170000603	Conklin et al.	Jan 2017	A1
20170000604	Conklin et al.	Jan 2017	A1
20170035568	Lombardi et al.	Feb 2017	A1
20170056171	Cooper et al.	Mar 2017	A1
20170079780	Schweich, Jr. et al.	Mar 2017	A1
20170128199	Gurovich et al.	May 2017	A1
20170128204	Morriss et al.	May 2017	A1
20170128209	Morriss et al.	May 2017	A1
20170156859	Chang	Jun 2017	A1
20170165064	Nyuli et al.	Jun 2017	A1
20170209266	Lane et al.	Jul 2017	A1
20170216023	Lane et al.	Aug 2017	A1
20170216026	Quill et al.	Aug 2017	A1
20170216029	Crowley	Aug 2017	A1
20170216575	Asleson et al.	Aug 2017	A1
20170252153	Chau et al.	Sep 2017	A1
20170258614	Griffin	Sep 2017	A1
20170273787	Passman et al.	Sep 2017	A1
20170319341	Jimenez et al.	Nov 2017	A1
20170325954	Perszyk	Nov 2017	A1
20170348096	Anderson	Dec 2017	A1
20180000582	Tuval et al.	Jan 2018	A1
20180021129	Peterson et al.	Jan 2018	A1
20180021132	Ottma et al.	Jan 2018	A1
20180028177	van Oepen et al.	Feb 2018	A1
20180049873	Manash	Feb 2018	A1
20180055629	Oba et al.	Mar 2018	A1
20180055636	Valencia et al.	Mar 2018	A1
20180085218	Eidenschink	Mar 2018	A1
20180092744	von Oepen et al.	Apr 2018	A1
20180104051	Salahieh et al.	Apr 2018	A1
20180104052	Salahieh et al.	Apr 2018	A1
20180104055	Salahieh et al.	Apr 2018	A1
20180104056	Salahieh et al.	Apr 2018	A1
20180110534	Gavala et al.	Apr 2018	A1
20180110622	Gregg	Apr 2018	A1
20180116843	Schreck et al.	May 2018	A1
20180125642	White et al.	May 2018	A1
20180125646	Bruchman et al.	May 2018	A1
20180125651	Nasr	May 2018	A1
20180126127	Devereux et al.	May 2018	A1
20180133006	Jones et al.	May 2018	A1
20180185179	Murphy et al.	Jul 2018	A1
20180193140	Weber	Jul 2018	A1
20180206983	Noe et al.	Jul 2018	A1
20180207010	Kheradvar	Jul 2018	A1
20180235657	Abunassar	Aug 2018	A1
20180235658	Perszyk et al.	Aug 2018	A1
20180250126	O'Connor et al.	Sep 2018	A1
20180250130	Hariton et al.	Sep 2018	A1
20180256323	Hariton et al.	Sep 2018	A1
20180271651	Christianson et al.	Sep 2018	A1
20180271653	Vidlund et al.	Sep 2018	A1
20180280171	Gloss	Oct 2018	A1
20180296335	Miyashiro	Oct 2018	A1
20180296336	Cooper et al.	Oct 2018	A1
20180296378	Aristizabal	Oct 2018	A1
20180296801	Tegg et al.	Oct 2018	A1
20180303606	Rothstein et al.	Oct 2018	A1
20180303609	Kenny et al.	Oct 2018	A1
20180325668	Morrissey et al.	Nov 2018	A1
20180333259	Dibie	Nov 2018	A1
20180353292	Keidar	Dec 2018	A1
20180360603	Levi	Dec 2018	A1
20190008639	Landon et al.	Jan 2019	A1
20190008640	Cooper et al.	Jan 2019	A1
20190021850	Nathe et al.	Jan 2019	A1
20190030285	Prabhu et al.	Jan 2019	A1
20190038404	Iamberger et al.	Feb 2019	A1
20190038405	Iamberger et al.	Feb 2019	A1
20190069997	Ratz et al.	Mar 2019	A1
20190070001	Calomeni et al.	Mar 2019	A1
20190083243	Hariton et al.	Mar 2019	A1
20190083244	Hariton et al.	Mar 2019	A1
20190083245	Hariton et al.	Mar 2019	A1
20190083246	Hariton et al.	Mar 2019	A1
20190083247	Hariton et al.	Mar 2019	A1
20190083248	Hariton et al.	Mar 2019	A1
20190083249	Hariton et al.	Mar 2019	A1
20190083250	Hariton et al.	Mar 2019	A1
20190083251	Hariton et al.	Mar 2019	A1
20190083252	Hariton et al.	Mar 2019	A1
20190083253	Hariton et al.	Mar 2019	A1
20190083254	Hariton et al.	Mar 2019	A1
20190110893	Haarer et al.	Apr 2019	A1
20190175338	White et al.	Jun 2019	A1
20190175342	Hariton et al.	Jun 2019	A1
20190192293	Yu et al.	Jun 2019	A1
20190247188	Wallace	Aug 2019	A1

Foreign Referenced Citations (138)

Number	Date	Country
2304325	Oct 2000	CA
2827556	Jul 2012	CA
1745727	Mar 2006	CN
102006052564	Dec 2007	DE
202007018551	Dec 2008	DE
0680351	Nov 1995	EP
0778039	Jun 1997	EP
0778040	Jun 1997	EP
0657147	Aug 1999	EP
0713408	Oct 2001	EP
1259194	Feb 2005	EP
1171059	Nov 2005	EP
1478307	Nov 2006	EP
1735038	Dec 2006	EP
1255510	Apr 2007	EP
1768732	Apr 2007	EP
1768738	Apr 2007	EP
1827558	Sep 2007	EP
1239901	Oct 2007	EP
1868530	Dec 2007	EP
1895943	Mar 2008	EP
1922038	May 2008	EP
1945141	Jul 2008	EP
1988851	Nov 2008	EP
2007325	Dec 2008	EP
2018204	Jan 2009	EP
1472996	Sep 2009	EP
2109416	Oct 2009	EP
1709987	Dec 2009	EP
1935377	Mar 2010	EP
1469793	Jun 2010	EP
1978895	Jun 2010	EP
2250975	Nov 2010	EP
0688576	Dec 2010	EP
2308425	Apr 2011	EP
1526887	Sep 2011	EP
2370028	Oct 2011	EP
2397108	Dec 2011	EP
2398543	Dec 2011	EP
1281375	Feb 2012	EP
2421479	Feb 2012	EP
2074964	Mar 2012	EP
2218425	May 2012	EP
2445568	May 2012	EP
2453970	May 2012	EP
2459266	Jun 2012	EP
2496182	Sep 2012	EP
2285317	Dec 2012	EP
2566416	Mar 2013	EP
2319458	Apr 2013	EP
2605725	Jun 2013	EP
2605729	Jun 2013	EP
2608741	Jul 2013	EP
2616004	Jul 2013	EP
2616006	Jul 2013	EP
2616007	Jul 2013	EP
2629706	Aug 2013	EP
2073756	Oct 2013	EP
2670357	Dec 2013	EP
2167179	Feb 2014	EP
2699201	Feb 2014	EP
1369098	Apr 2014	EP
2739214	Jun 2014	EP
2117469	Jul 2014	EP
2124826	Jul 2014	EP
2419050	Jul 2014	EP
2750630	Jul 2014	EP
2750631	Jul 2014	EP
2771064	Sep 2014	EP
2777616	Sep 2014	EP
2777617	Sep 2014	EP
1765445	Mar 2015	EP
2870946	May 2015	EP
2745805	Jun 2015	EP
2749254	Jun 2015	EP
2877132	Jun 2015	EP
2898858	Jul 2015	EP
2250976	Aug 2015	EP
2590595	Aug 2015	EP
2921139	Sep 2015	EP
1734903	Oct 2015	EP
2962664	Jan 2016	EP
2967858	Jan 2016	EP
2926766	Feb 2016	EP
2985006	Feb 2016	EP
2168536	Apr 2016	EP
2238947	Apr 2016	EP
2815725	Apr 2016	EP
2237746	May 2016	EP
2582326	May 2016	EP
2453969	Jun 2016	EP
2901966	Jun 2016	EP
2815723	Jul 2016	EP
2618779	Aug 2016	EP
2853238	Aug 2016	EP
3062745	Sep 2016	EP
3069696	Sep 2016	EP
3073965	Oct 2016	EP
3075354	Oct 2016	EP
3107497	Dec 2016	EP
3107500	Dec 2016	EP
3111888	Jan 2017	EP
2967931	Feb 2017	EP
2262451	May 2017	EP
2538880	May 2017	EP
2351541	Jun 2017	EP
3184083	Jun 2017	EP
2480167	Aug 2017	EP
2865355	Sep 2017	EP
3256073	Dec 2017	EP
2446915	Jan 2018	EP
3057541	Jan 2018	EP
2934392	Feb 2018	EP
3283011	Feb 2018	EP
3037064	Mar 2018	EP
3046511	Mar 2018	EP
3142603	Mar 2018	EP
3290004	Mar 2018	EP
3294220	Mar 2018	EP
3316822	May 2018	EP
3316823	May 2018	EP
2379322	Jun 2018	EP
3335672	Jun 2018	EP
3344190	Jul 2018	EP
2967845	Aug 2018	EP
3081195	Oct 2018	EP
3426193	Jan 2019	EP
2379009	Feb 2019	EP
2793991	Feb 2019	EP
3468480	Apr 2019	EP
2663259	May 2019	EP
3496664	Jun 2019	EP
1264471	Feb 1972	GB
1315844	May 1973	GB
2245495	Jan 1992	GB
2398245	Aug 2004	GB
2002540889	Dec 2002	JP
2008541865	Nov 2008	JP

Non-Patent Literature Citations (52)

Entry
Backer, Ole De, MD, et al., “Percutaneous Transcatheter Mitral Valve Replacement—An Overview of Devices in Preclinical and Early Clinical Evaluation,” Contemporary Reviews in Interventional Cardiology, Circ Cardiovasc Interv. 2014;7:400-409, Applicant believes this may have been available as early as Jun. of 2014.
Banai, Shmeul et al., The Journal of the American College of Cardiology, “Transapical Mitral Implantation of the Tiara Bioprosthesis Pre-Clinical Results,” Feb. 2014, <http://interventions.onlinejacc.org/article.aspx?articleid=1831234>.
Bavaria, Joseph E M.D.: “CardiAQ Valve Technologies: Transcatheter Mitral Valve Implantation,” Sep. 21, 2009.
Bavaria, Joseph E. M.D et al.: “Transcatheter Mitral Valve Implantation: The Future Gold Standard for MR?,” Applicant requests the Examiner to consider this reference to be prior art as of Dec. of 2010.
Berreklouw, Eric, PhD, et al., “Sutureless Mitral Valve Replacement With Bioprostheses and Nitinol Attachment Rings: Feasibility In Acute Pig Experiments,” The Journal of Thoracic and Cardiovascular Surgery, vol. 142, No. 2, Aug. 2011 in 7 pages, Applicant believes this may have been available online as early as Feb. 7, 2011.
BioSpace, “CardiAQ Valve Technologies (CVT) Reports Cardiovascular Medicine Milestone: First-In-Humannonsurgical Percutaneous Implantation of a Bioprosthetic Mitral Heart Valve,” Jun. 14, 2012, p. 1, http://www.biospace.com/News/cardiaq-valve-technologies-cvt-reports/263900.
BioSpace, “CardiAQ Valve Technologies (CVT) Reports First-In-Human Percutaneous Transfemoral, Transseptal Implantation With Its Second Generation Transcatheter Bioprosthetic Mitral Heart Valve,” Jun. 23, 2015, p. 1, http://www.biospace.com/News/cardiaq-valve-technologies-cvt-reports-first-in/382370.
Boudjemline, Younes, et al., “Steps Toward the Percutaneous Replacement of Atrioventricular Valves,” JACC, vol. 46, No. 2, Jul. 19, 2005:360-5.
“CardiAQTM Valve Technologies reports Successful First-in-Human Trans-Apical implantation of its Second Generation Transcatheter Mitral Valve,” CardiAQ Valve Technologies Press Release, May 20, 2014.
“Company Overview,” at TVT on Jun. 25, 2009.
Chiam, Paul T.L., et al., “Percutaneous Transcatheter Aortic Valve Implantation: Assessing Results, Judging Outcomes, and Planning Trials,” JACC: Cardiovascular Interventions, The American College of Cardiology Foundation, vol. 1, No. 4, Aug. 2008:341-50.
CardiAQ Valve Technologies, “Innovations in Heart Valve Therapy,” In3 San Francisco, Jun. 18, 2008, PowerPoint presentation in 19 slides.
Condado, Jose Antonio, et al., “Percutaneous Treatment of Heart Valves,” Rev Esp Cardio. 2006;59(12):1225-31, Applicant believes this may have been available as early as Dec. of 2006.
Engager System, Precise Valve Positioning, Transcatheter Aortic Valve Implantation System, Transcatheter Aortic Valve Replacement—TAVR I Medtronic Engager, http://www.medtronic-engager.com/home/transcatheter-aortic-valve-repl., 2014 Medtronic, Inc. in 2 pages. Applicant believes this may have been available online as early as Aug. 25, 2013.
Fanning, Jonathon P., et al., “Transcatheter Aortic Valve Implantation (TAVI): Valve Design And Evolution,” International Journal of Cardiology 168 (2013) 1822-1831, Applicant believes this may have been available as eariy as Oct. 3, 2013.
Fornell, Dave, “Transcatheter Mitral Valve replacement Devices in Development,” Diagnostic and Interventional Cardiology, Dec. 30, 2014, p. 3, <http://www.dicardiology.com/article/transcatheter-mitial-valve-replacement-devices-development>.
Feldman, Ted, MD. “Prospects for Percutaneous Valve Therapies,” Circulation 2007; 116:2866-2877. Applicant believes that this may be available as early as Dec. 11, 2007.
Fitzgerald, Peter J. M.D., “Tomorrow's Technology: Percutaneous Mitral Valve Replacement, Chordal Shortening, and Beyond,” Transcatheter Valve Therapies (TVT) Conference. Seattle, WA. Applicant believes this may have been available as early as Jun. 7, 2010.
Grube, E. et al., “Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome.” J Am Coll Cardiol. Jul. 3, 2007;50(1):69-76. Epub Jun. 6, 2007.
Horvath et al.: “Transapical Aortic Valve Replacement under Real-time Magnetic Resonance Imaging Guidance: Experimental Results with Balloon- Expandable and Self-Expanding Stents,” http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038190/. Jun. 2011.
Karimi, Houshang, et al., “Percutaneous Valve Therapies,” SIS 2007 Yearbook, Chapter 11, pp. 1-11.
Kronemyer, Bob, “CardiAQ Valve Technologies: Percutaneous Mitral Valve Replacement,” Start Up—Windhover Review of Emerging Medical Ventures, vol. 14, Issue No. 6, Jun. 2009, pp. 48-49.
Leon, Martin B., et al., “Transcatheter Aortic Valve Replacement in Patients with Critical Aortic Stenosis: Rationale, Device Descriptions, Early Clinical Experiences, and Perspectives,” Semin. Thorac. Cardiovasc. Surg. 18:165-174, 2006 in 10 pages, Applicant believes this may have been available as early as the Summer of 2006.
Lutter, Georg, et al., “Off-Pump Transapical Mitral Valve Replacement,” European Journal of Cardio-thoracic Surgery 36 (2009) 124-128, Applicant believes this may have been available as early as Apr. 25, 2009.
Mack, Michael, M.D., “Antegrade Transcatheter Mitral valve Implantation: On-Going Experience in Swine Model,” Applicant believes this may have been presented on Nov. of 2011 at TCT.
Mack, Michael, M.D., “Antegrade Transcatheter Mitral valve Implantation: A Short-term Experience in Swine Model,” Applicant believes this may have been presented on May of 2011 at TVT.
Ma, Liang, et al., “Double-Crowned Valved Stents For Off-Pump Mitral Valve Replacement,” European Journal of Cardio-thoracic Surgery 28 (2005) 194-199, Applicant believes this may have been available as early as Aug. of 2005.
Mack, Michael M.D., “Advantages and Limitations of Surgical Mitral Valve Replacement; Lessons for the Transcatheter Approach,” Applicant believes this may have been available as early as Jun. 7, 2010. Applicant believes this may have been presented at the Texas Cardiovascular Innovative Ventures (TCIV) Conference in Dallas, TX on Dec. 8, 2010.
Masson, Jean-Bemard, et al., “Percutaneous Treatment of Mitral Regurgitation,” Circulation: Cardiovascular Interventions, 2:140-146, Applicant believes this may have been available as early as Apr. 14, 2009.
NJ350: Vote for Your Favorite New Jersey Innovations, Jun. 27, 2014, http://www.kilmerhouse.com/2014/06/nj350-vote-for-your-favorite-new-jersey-innovations/.
Neovasc corporate presentation, Oct. 2009, available at http://www.neovasc.com/investors/documents/Neovasc-Corporate-Presentation-October.2009.pdf.
Ostrovsky, Gene, “Transcatheter Mitral Valve Implantation Technology from CardiAQ,” medGadget, Jan. 15, 2010, available at: http://www.medgadget.com/2010/01/transcatheter_mitral_valve_implantation_technology_from_cardiaq.html.
Pluth, James R., M.D., et al., “Aortic and Mitral Valve Replacement with Cloth-Covered Braunwald-Cutter Prosthesis, A Three-Year Follow-up,” The Annals Of Thoracic Surgery, vol. 20, No. 3, Sep. 1975, pp. 239-248.
Piazza, Nicoló, MD, et al., “Anatomy of the Aortic Valvar Complex and Its Implications for Transcatheter Implantation of the Aortic Valve,” Contemporary Reviews in Interventional Cardiology, Circ. Cardiovasc. Intervent., 2008;1:74-81, Applicant believes this may have been available as early as Aug. of 2008.
Preston-Maher, Georgia L., et al., “A Technical Review of Minimally Invasive Mitral Valve Replacements,” Cardiovascular Engineering and Technology, vol. 6, No. 2, Jun. 2015, pp. 174-184. Applicant believes this may have been available as early as Nov. 25, 2014.
Quadri, Arshad M.D., “Transcatheter Mitral Valve Implantation (TMVI) (An Acute In Vivo Study),” Applicant believes this may have been presented on Sep. 22, 2010 at TCT.
Ratz, J. Brent et al., “Any experiences making an expandable stent frame?” Arch-Pub.com, Architecture Forums: Modeling, Multiple forum postings from Feb. 3, 2009 to Feb. 4, 2009, http://www.arch-pub.com.
Ratz, J. Brent, “LSI EMT Spotlight,” May 15, 2009.
Ruiz, Carlos E., “Overview of Novel Transcatheter Valve Technologies,” Applicant believes this may have been presented on May 27, 2010 at EuroPCR.
Raiz, J. Brent, “In3 Company Overview,” Jun. 24, 2009.
Seidel, Wolfgang, et al., “A Mitral Valve Prosthesis and a Study of Thrombosis on Heart Valves in Dogs,” JSR—vol. II, No. 3—May 1962, submitted for publication Oct. 9, 1961.
Sondergaard, Lars, et al., “Transcatheter Mitral Valve Implantation: CardiAQ™,” Applicant believes this may have been presented at TCT 2013.
Sondergaard, Lars, “CardiAQ TMVR FIH—Generation 2,” Applicants believe this may have been presented in 2014 at the TVT symposium.
Sondergaard, Lars, et al., “Transcatheter Mitral Valve Implantation: CardiAQ™,” Applicant believes this may have been presented at EuroPCR 2013.
Spillner, J. et al., “New Sutureless ‘Atrial- Mitral-Valve Prosthesis’ For Minimally Invasive Mitral Valve Therapy,” Textile Research Journal, 2010, in 7 pages, Applicant believes this may have been available as early as Aug. 9, 2010.
Taramasso et al.: “New devices for TAVI: technologies and initial clinical experiences” http://www.nature.com/nrcardio/journal/v11/n3/full/nrcardio.2013.221..html?message-global=remove#access. Jan. 21, 2014.
Treede et al.: “Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study.” http://ejcts.oxfordjoumals.org/content/41/6/e131.long. Apr. 16, 2012.
“Update,” Applicant believes this may have been presented on Jun. 6, 2010 at TVT.
Van Mieghem, et al., “Anatomy of the Mitral Valvular Complez and Its Implications for Transcatheter Interventions for Mitral Regurgitation,” J. Am. Coll. Cardiol., 56:617-626 (Aug. 17, 2010).
Vu, Duc-Thang, et al., “Novel Sutureless Mitral Valve Implantation Method Involving A Bayonet Insertion And Release Mechanism: A Proof Of Concept Study In Pigs,” The Journal of Thoracic and Cardiovascular Surgery, vol. 143, No. 4, 985-988, Apr. 2012, Applicant believes this may have been available online as early as Feb. 13, 2012.
Wayback Machine, Cleveland Clinic Lerner Research Institute, Transcatheter Mitral Stent/Valve Prosthetic, https://web.archive.org/web/20130831094624/http://mds.clevelandclinic.org/Portfolio.aspx?n=331, indicated as archived on Aug. 31, 2013.
Webb, John G., et al., “Transcatheter Aortic Valve Implantation: The Evolution Of Prostheses, Delivery Systems And Approaches,” Archives of Cardiovascular Disease (2012) 105, 153-159. Applicant believes this may have been available as early as Mar. 16, 2012.

Related Publications (1)

	Number	Date	Country
	20200345494 A1	Nov 2020	US

Provisional Applications (1)

	Number	Date	Country
	62622036	Jan 2018	US

Continuations (1)

	Number	Date	Country
Parent	PCT/US2019/014999	Jan 2019	US
Child	16934879		US

Delivery system for aided replacement valve recapture and repositioning post-deployment

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

CPC

International Classifications

Term Extension

Abstract